US20140142689A1 - Device and method of treating heart valve malfunction - Google Patents
Device and method of treating heart valve malfunction Download PDFInfo
- Publication number
- US20140142689A1 US20140142689A1 US13/691,087 US201213691087A US2014142689A1 US 20140142689 A1 US20140142689 A1 US 20140142689A1 US 201213691087 A US201213691087 A US 201213691087A US 2014142689 A1 US2014142689 A1 US 2014142689A1
- Authority
- US
- United States
- Prior art keywords
- chord
- valve leaflet
- heart
- recited
- anchor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0643—Surgical staples, i.e. penetrating the tissue with separate closing member, e.g. for interlocking with staple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
- A61F2/2457—Chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0482—Needle or suture guides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
- A61B2017/0437—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being resilient or spring-like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0448—Additional elements on or within the anchor
- A61B2017/045—Additional elements on or within the anchor snug fit within the anchor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
Definitions
- the present invention is directed to an instrument assembly and method of use and application in the treatment of heart valve malfunction.
- the instrument assembly is specifically adapted to treat mitral regurgitation by means of a direct entry of the instrument through the atrial wall rather than through the vascular system, in order to apply sufficient tension to a prolapsing leaflet, including the anterior leaflet and/or the posterior leaflet of the mitral valve, in order to overcome mitral regurgitation.
- the human heart is a four chambered pump that moves blood efficiently through the vascular system.
- blood enters the heart through the vena cava and flows into the right atrium. Thereafter, blood flows from the right atrium through the tricuspid valve and into the right ventricle.
- blood is forced through the pulmonic valve and into the lungs for oxygenation.
- the oxygenated blood returns from the lungs and enters the heart through the left atrium and passes through the mitral valve into the left ventricle.
- the blood therein flows through the aortic valve and into the aorta and throughout the vascular system.
- the mitral valve is disposed in flow regulating communication between the left atrium and the left ventricle. It is composed of two valve leaflets, the mitral valve annulus, which forms a ring that supports the valve leaflets; papillary muscles, which tether the valve leaflets to the left ventricle wall, by preventing them from prolapsing back into the left atrium. Chordae tendineae serve to connect the mitral valve leaflets to the papillary muscles thereby further preventing the leaflets from prolapsing back into the left atrium. A dysfunction of any of these components of the mitral valve can cause “mitral regurgitation”. Mitral regurgitation is a disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood.
- mitral regurgitation is the second most common form of valvular heart disease.
- the anterior and posterior valve leaflets of the mitral valve overlap during contraction of the left ventricle and prevent blood from flowing back into the left atrium.
- This overlap of the 2 leaflets leaning upon each other is called the coaptation and absorbs most of the strain on the mitral apparatus during the ventricular contraction.
- the mitral valve malfunctions, due to various cardiac diseases, the leaflets are no longer coapting resulting in the mitral valve remaining partially open during ventricular contraction. In turn this allows the “regurgitation” of the blood back into the left atrium, as generally set forth above.
- Methods of treating conditions relating to the malfunctioning of the heart valve specifically including valve incompetencies, mitral valve leakage and other heart failure conditions may be in various stages of development such as the extending of an elongate member transverse across a corresponding or affected heart chamber.
- Each end of the elongate member extends through a wall of the heart such as the septum wall and an oppositely disposed wall portion, wherein first and second anchoring members are connected to corresponding ends of the elongate member but are disposed external of the heart chamber.
- Connecting clips or the like are applied to the corresponding exterior ends of the elongate member, resulting in the papillary muscles within the chamber to be effectively repositioned.
- a predetermined force is applied to the heart itself and/or the affected portions of the heart chamber.
- mitral regurgitation sometimes may include the replacement of the mitral valve, resulting in traumatic and frequently dangerous surgical procedures being performed on a patient.
- the present invention is directed to an instrument assembly and attendant method for treating heart valve malfunction.
- the instrumentation and method are specifically, but not exclusively, adapted for the treatment of mitral regurgitation.
- the subject instrument assembly and method will be described generically regarding treatment of a predetermined heart valve.
- the present invention will be more specifically described in regard to a procedure involving correction of a prolapsing mitral valve leaflet, which may include the anterior mitral valve leaflet and/or the posterior valve leaflet correcting of mitral regurgitation.
- the instrument assembly of the present invention includes an introductory sheath formed of a material of sufficient rigidity to facilitate the penetration and passage through various portions of the heart and mitral valve.
- the introductory sheath may be said to be formed of at least a “semi-rigid” material.
- this term is to be understood to include material having sufficient flexibility to be manipulated or “steered” through and/or along a predetermined path during the delivery of the sheath and associated components of the instrument assembly to predetermined portions of the heart.
- the sheath will be sufficiently maneuverable to pass through the atrial wall into interior portions of the heart such as the left atrium and left ventricle.
- an introduction assembly and a delivery catheter will be used to facilitate the positioning the introductory sheath into the thoracic cavity and through the atrial wall or other preferred exterior locations of the heart wall.
- Additional structural operative features of the instrument assembly include the provision and utilization of at least one, or under required circumstances, more than one elongated chord formed of a biocompatible material and being at least partially flexible.
- the material from which the chord is formed should have sufficient and/or predetermined tensile strength to exert a predetermined tension on the predetermined, prolapsing valve leaflet as the chord extends between a corresponding portion of the heart wall, such as the ventricular wall, as also more fully described hereinafter.
- the chord is initially housed concentrically within the interior of the introductory sheath, wherein the sheath and the chord are concurrently movable relative to the heart as well as throughout a portion of the interior thereof.
- the introductory sheath is formed of a material having physical characteristics that allow it to be accurately manipulated so as to be steerable in such a manner that its tip can aim towards the different designated portions of the anterior or posterior mitral valve leaflets that are in the siege of the prolapse.
- the exteriorly concentric introductory sheath is movable relative to and along the length of the chord so as to accommodate proper and intended placement and anchoring of the chord within the heart chamber. Therefore, the sheath is movable with the chord into and through predetermined portions of the heart chamber and movable relative to the chord after proper anchoring, securing and/or intended placement of the chord within the heart chamber.
- the instrument assembly of the present invention also includes an anchor secured to an outer or distal end of the chord.
- the anchor may also be sufficiently sharpened, pointed or otherwise configured to penetrate an intended heart valve leaflet, such as a prolapsing leaflet of the mitral valve. Further, the penetration and passage of the anchor, the chord, and the introductory sheath substantially through the predetermined valve leaflet may thereby be facilitated.
- the anchor When properly positioned, the anchor is structured to be secured to a substantially opposing portion of the heart wall, such as the ventricular wall associated with the left ventricle and/or the papillary muscles associated therewith.
- a gripping structure may be operatively attached to a remainder of the anchor and disposable into an outwardly and/or radially extending orientation. When so disposed, the gripping structure, in combination with the remainder of the anchor, eliminates or significantly restricts the inadvertent detachment of the anchor, and the distal end of the chord attached thereto, from the corresponding ventricular wall portion.
- the anchor and the gripping structure are disposed and applied so as to penetrate the corresponding portion of the ventricular wall but not extend there through. Therefore, the anchored relation of the gripping structure, anchor and the connected distal end of the chord may be defined by a penetration into the interior of the ventricular wall rather than a passage completely there through. Complications associated with sealing and exterior attachment of the chord to the exterior of the ventricular wall are thereby eliminated.
- the present invention further comprises a method of treating heart and valve malfunction utilizing the instrument as generally set forth above.
- the attendant method comprises, at least in more generic terms, the passing of a portion of the instrument assembly into an intended heart chamber and into penetrating relation to a predetermined valve leaflet, such as a prolapsing leaflet.
- a predetermined valve leaflet such as a prolapsing leaflet.
- the sheath, with the chord concentrically disposed on the interior thereof, is passed through the predetermined valve leaflet. Therefore, by virtue of the enclosed disposition of the chord, the chord and sheath will concurrently enter and extend through the predetermined valve leaflet.
- the sheath and the chord will extend across a corresponding heart chamber and into an anchored relation with a substantially opposing portion of the heart wall.
- the sheath is withdrawn from heart chamber in which the chord is anchored. More specifically, the sheath is withdrawn by moving relative to and back along the length of the anchored chord in a direction away from the anchor and connected distal end of the chord. The introductory sheath is further withdrawn back through the predetermined valve leaflet while the proximal portion of the chord remains within the valve leaflet.
- a securing assembly is operatively disposed within the heart chamber in interconnecting relation between a proximal extremity of the chord and the predetermined valve leaflet.
- the securing assembly may include a securing member, which will be mounted on or connected to a proximal portion of the chord and moved along the length thereof into a predetermined, interconnecting position relative to the prolapsing valve leaflet.
- the position of the securing member will be tailored to and disposed at the exact position needed to achieve correction of the mitral regurgitation, which may be determined by preoperative transoesopageal echography or other preoperative manner, to quantify the occurring mitral regurgitation preoperatively.
- the securing member then securely interconnects the proximal extremity of the chord to the predetermined valve leaflet and any excess length of the chord will be severed or detached from the proximal extremity of the chord, which is secured to the surface of the leaflet associated with the atrium.
- the chord is thereby properly tensioned between the opposing, interior corresponding wall portion of the heart and the predetermined valve leaflet so as to overcome the malfunction of the predetermined valve leaflet as explained in more specific details hereinafter.
- the instrument assembly and attendant method of the present invention is specifically adapted for the treatment of mitral regurgitation.
- the introductory sheath and the chord substantially concurrently enter the atrial wall of the left atrium and pass into the interior thereof. Further, the sheath and the chord penetrate and are passed, substantially concurrently, through a prolapsing (flail) anterior or posterior leaflet of the mitral valve into the left ventricle of the heart chamber. Thereafter the sheath and chord are concurrently extended transversely across the left ventricle, wherein the anchor penetrates and is thereby secured in an anchored relation with a substantially opposing portion of the ventricular wall and/or corresponding papillary muscles. The distal end of the chord is connected to the anchor and is thereby secured in an anchored relation to the ventricular wall, by virtue of the penetrating anchor.
- the sheath is withdrawn back along the length of the chord, away from the anchor and the ventricular wall to which the distal portion of the chord is secured. Moreover, the introductory sheath continues to travel back along the length of the chord through the prolapsing anterior or posterior mitral valve leaflet to a location at least exterior to the leaflet, such as within the left atrium and possibly exteriorly of the heart itself.
- a securing assembly is then operatively associated with the instrument and is movably disposed along the length of a proximal portion of the chord.
- the movement of the securing assembly and its associated securing member are disposed into an interconnecting position between a proximal extremity of the chord and the mitral valve leaflet penetrated by the chord.
- proper tensioning is thereby placed on the prolapsing mitral valve leaflet in order to restore a sufficient surface of coaptation between its counterpart, opposing leaflet and maintain the suppressed leaflet in an operative position sufficient to overcome the mitral regurgitation.
- FIG. 1 is a perspective view of one preferred embodiment of the instrument assembly of the present invention used in the treatment of heart valve malfunction.
- FIG. 1A is a perspective view of the instrument assembly of the embodiment of FIG. 1 in an initially introductory position.
- FIGS. 2 through 9 are schematic representations of successive steps in the attendant method of utilizing and applying the instrument assembly of the embodiment of FIGS. 1 and 1A specifically for the treatment and correction of mitral regurgitation.
- the instrument assembly of the present invention is schematically and generally indicated as 10 and is used for the treatment of heart valve malfunction generally and more specifically for the treatment of mitral regurgitation.
- the instrument assembly 10 includes an elongated delivery catheter or tube 12 having a hollow interior and structured to deliver operative portions of the instrument assembly 10 to the treatment site within the heart of a patient.
- the elongated delivery catheter or tube 12 is dimensioned and configured to enter the chest cavity through appropriate introduction instrumentation.
- the delivery tube 12 is formed of a material and/or includes positioning structure or linkage incorporated therein which facilitates the maneuvering or steering thereof to a point at least generally exterior the heart and more specifically the atrial wall of the left atrium.
- the at least semi-rigid material of the delivery tube 12 should be sufficient to also facilitate proper manipulation so as to position or “steer” the remainder of the instrument assembly 10 to the intended location within the interior thereof, as well as facilitate penetration of and anchoring to intended tissue portions.
- the instrument assembly 10 also includes an introductory sheath 14 movable within the delivery tube 12 and an elongated flexible material chord 16 .
- the introductory sheath 14 is concentrically and movably enclosed within the delivery tube 12 and the sheath 14 is movably disposed concentrically about the chord 16 .
- FIG. 1 represents a completely assembled instrument assembly 10 .
- the various portions of the instrument assembly 10 are used in successive steps to accomplish installation relative to the affected portions of the heart valve being treated.
- the instrument assembly 10 further includes the elongated flexible material chord 16 which may be formed of a synthetic, biocompatible material.
- An anchor 18 is fixedly secured to the outer or distal end of the chord 16 and is movable therewith relative to the introductory sheath 14 .
- chord 16 is at least initially enclosed concentrically within the interior of the introductory sheath 14 , wherein the sheath 14 is movable along the length of the chord 16 .
- the sheath includes an open distal end 14 ′ serving to at least partially encloses or be registered alignment with the anchor 18 . Therefore, FIG. 1A represents cooperative portions of the instrument assembly 10 at least upon initial entry of the introductory sheath 14 and anchor 18 into the interior of the heart 30 , as specifically described in detail in FIGS. 2 through 9 , hereinafter described.
- the positioning of the anchor 18 , the introductory sheath 14 and the chord 16 is such that the chord 16 is disposed within the interior of the introductory sheath 14 .
- the anchor 18 is disposed at least partially within and/or in an exposed relation to the open distal end 14 ′ of the sheath 14 .
- the anchor 18 has a sharpened, pointed or other appropriate configuration for penetrating portions of the heart.
- the anchor 18 may also include a gripping structure 20 which may be initially disposed in a collapsed position when the anchor 18 is in registry with the distal opening 14 ′ of the sheath 14 .
- the gripping structure 20 may include an inherent bias causing it to expand outwardly and/or radially from the remainder of the anchor 18 .
- This gripping structure 20 is provided to facilitate a secure engagement of the anchor 18 with predetermined heart wall portions, when the instrument assembly 10 is properly applied in the treatment of the heart valve malfunction.
- the assembled representation of the instrument assembly 10 further includes the provision of a securing member 22 which may travel along the length of the chord 16 .
- the securing member may be forcibly positioned into an intended interconnecting location relative to a heart valve leaflet in order to accomplish a secure attachment of the chord 16 to the leaflet as will be explained in greater detail hereinafter.
- Such an interconnecting placement of the securing member 22 relative to both the chord 16 and the affected valve leaflet serves to establish and maintain a sufficient tension and/or positioning force on the predetermined valve leaflet to suppress movement thereof, as explained hereinafter with regard to FIGS. 2 through 9 .
- the heart is generally indicated as 30 and includes the representative portions including the left atrium 32 , the left ventricle 34 and the mitral valve 36 , including the anterior and posterior mitral valve leaflets 38 and 38 ′, respectively.
- the left ventricle 34 is at least partially bordered or surrounded by ventricular wall 40 which may be directly associated with corresponding papillary muscles (not shown) facilitating the proper positioning of the mitral valve leaflets 38 and 38 ′ through organic tissue tethering, as generally outlined above.
- FIGS. 2-9 schematically represent the instrument assembly 10 used on the anterior leaflet 38 of the mitral valve 30 in order to treat and correct mitral regurgitation.
- the instrument assembly 10 and the attendant method of the present invention may be applied to an anterior and/or the posterior prolapsing leaflet in the manner described herein, in correcting a mitral regurgitation condition of the heart.
- the various embodiments of the present invention are described using a single chord 16 , a plurality of chords 16 may be used with the cooperative instrument components of the instrument assembly 10 .
- the instrument assembly 10 is introduced into the interior of the heart 30 and more specifically into the left atrium 32 , through the atrium wall 33 , using an appropriate introduction assembly 42 . Therefore, the introductory sheath 14 and the chord 16 located concentrically within the sheath 14 will concurrently pass through the atrial wall 33 of the heart into the left atrium 32 , as it is directed towards the anterior leaflet 38 of the mitral valve 36 .
- the anchor 18 is at least initially in the position generally represented in FIG. 1A . Due to its predetermined configuration the anchor 18 will serve to approach and penetrate the anterior leaflet 38 of the mitral valve 36 as clearly represented in FIG. 3 .
- the penetration of the anterior leaflet 38 initially by the anchor 18 will facilitate the penetration and passage, substantially concurrently, of the chord 16 and the introductory sheath 14 through the anterior leaflet 38 as schematically represented.
- a continued force will be applied to the introductory sheath 14 causing the sheath 14 and interiorly disposed chord 16 , as well as the anchor 18 to continue concurrent passage through the anterior valve leaflet 38 until the anchor 18 reaches, penetrates and is secured to the ventricular wall 40 and/or correspondingly disposed papillary muscles associated therewith.
- the distal end of the chord 16 will be affixed to the ventricular wall 40 and remain in place as the introductory sheath 14 is withdrawn back along the length of the chord 16 , as indicated by the directional arrows.
- the aforementioned gripping structure 20 will have been expanded into a gripping orientation.
- the anchor 18 and the distal end of the chord 16 connected thereto will be reliably anchored or connected to the ventricular wall 40 .
- the securing assembly including securing member 22 , will move along the length of the chord 16 as it is introduced into the left atrium 32 such as through the atrium wall via, the introduction assembly 42 .
- the securing member 22 will be forced, moved, positioned, etc. along the proximal portion or length 16 ′ of the chord 16 by any appropriate technique and/or appropriate positioning instrument/device, which may be incorporated or operatively associated with the chord 16 .
- Positioning of the securing member 22 will continue until it is disposed in engaging, interconnecting and at least partially protective or sealing engagement with an exterior surface portion of the suppressed anterior mitral valve leaflet 38 located within the left atrium 32 .
- the position of the securing member 22 will be disposed in the exact position, on and along the length of the chord 16 needed to position and or suppress movement of the leaflet 38 to achieve correction of the mitral regurgitation.
- exact positioning may be determined by preoperative transoesopageal echography or other preoperative manner to quantify online mitral regurgitation preoperatively.
- One embodiment may also include a guiding element or sleeve 25 , as represented in FIG. 1 .
- the element 25 When utilized, the element 25 will be disposed at a predetermined position along the length on the artificial chord 16 and be mounted concentrically about and/or along a portion of the chord 16 .
- the guiding element 25 may assume and or be at least partially defined by a variety of different structures, devices and/or mechanisms other than, but possibly including, the schematically represented sleeve.
- the guiding element is operative to accurately center or otherwise dispose the securing member 22 in sealing and/or covering relation to the aperture or area where the chord 16 remains in its extended position through the anterior leaflet 38 .
- the securing member 22 securely connects the proximal extremity 16 ′′ of the chord 16 to the valve leaflet 38 and any excess length of the proximal portion 16 ′ of the chord 16 will be severed or detached from the extremity 16 ′′ of the chord 16 and the securing member 22 , which interconnects the proximal extremity 16 ′′ to the “exterior” surface of the leaflet 38 exposed to the left atrium 32 .
- manipulation of the instrument of the assembly 10 causes a severing of the proximal extremity from a remainder of the chord 16 .
- the securing member 22 serves to securely connect and fasten the chord 16 to the exterior of the anterior leaflet 38 , disposed within the left atrium 32 .
- the introductory sheath 14 passes back through the introduction assembly 42 so as to exit the left atrium 32 and the remainder of the heart. Thereafter, the introduction assembly 42 is also removed from its initial operative position.
- the heart 30 is represented with the synthetic chord 16 properly anchored between the ventricular wall 40 and the penetrated anterior leaflet 38 .
- proper tensioning or positioning forces are applied to the anterior leaflet 38 causing it to be positioned in a manner which effectively overcomes mitral regurgitation, as set forth above.
Abstract
An assembly and method for treating heart valve malfunction typically including treating of mitral regurgitation wherein an instrument assembly includes an elongated chord movably disposed within an introductory sheath and including an anchor secured to a distal end thereof. An attendant method includes concurrently introducing the sheath and the chord into the heart chamber through an exterior wall and penetrating and passing the sheath and the chord through the anterior mitral valve leaflet. The sheath and the chord are then extended transversely across the heart chamber and the distal end of the chord is anchored to an opposing portion of the heart wall. The sheath is then withdrawn back along the length of the anchored chord and through the anterior mitral valve leaflet and a securing member connects the proximal end of the chord to the valve leaflet. The chord is secured between the valve leaflet and the opposing heart wall under sufficient tension to maintain an intended positioning of the valve leaflet to overcome mitral regurgitation.
Description
- The present application is based on and a claim of priority is made under 35 U.S.C. Section 119(e) to a provisional patent application that is currently pending in the U.S. Patent and Trademark Office, namely, that having Ser. No. 61/729,152 and a filing date of Nov. 21, 2012, and which is incorporated herein by reference in its entirety.
- 1. Field of the Invention
- The present invention is directed to an instrument assembly and method of use and application in the treatment of heart valve malfunction. In more specific terms the instrument assembly is specifically adapted to treat mitral regurgitation by means of a direct entry of the instrument through the atrial wall rather than through the vascular system, in order to apply sufficient tension to a prolapsing leaflet, including the anterior leaflet and/or the posterior leaflet of the mitral valve, in order to overcome mitral regurgitation.
- 2. Description of the Related Art
- The human heart is a four chambered pump that moves blood efficiently through the vascular system. During normal operation, blood enters the heart through the vena cava and flows into the right atrium. Thereafter, blood flows from the right atrium through the tricuspid valve and into the right ventricle. Upon contraction of the right ventricle, blood is forced through the pulmonic valve and into the lungs for oxygenation. The oxygenated blood returns from the lungs and enters the heart through the left atrium and passes through the mitral valve into the left ventricle. Upon contraction of the left ventricle the blood therein flows through the aortic valve and into the aorta and throughout the vascular system.
- The mitral valve is disposed in flow regulating communication between the left atrium and the left ventricle. It is composed of two valve leaflets, the mitral valve annulus, which forms a ring that supports the valve leaflets; papillary muscles, which tether the valve leaflets to the left ventricle wall, by preventing them from prolapsing back into the left atrium. Chordae tendineae serve to connect the mitral valve leaflets to the papillary muscles thereby further preventing the leaflets from prolapsing back into the left atrium. A dysfunction of any of these components of the mitral valve can cause “mitral regurgitation”. Mitral regurgitation is a disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood. This abnormal leaking of blood from the left ventricle, through the mitral valve and, into the left atrium when the left ventricle contracts, results in the “regurgitation” of blood back into the left atrium. It is generally recognized in the medical profession that mitral regurgitation is the second most common form of valvular heart disease.
- As generally set forth above, when properly functioning, the anterior and posterior valve leaflets of the mitral valve overlap during contraction of the left ventricle and prevent blood from flowing back into the left atrium. This overlap of the 2 leaflets leaning upon each other is called the coaptation and absorbs most of the strain on the mitral apparatus during the ventricular contraction. However, when the mitral valve malfunctions, due to various cardiac diseases, the leaflets are no longer coapting resulting in the mitral valve remaining partially open during ventricular contraction. In turn this allows the “regurgitation” of the blood back into the left atrium, as generally set forth above. When the mitral valve does not close hermetically during the ventricular contraction, the aforementioned back flow of blood to the atrium and the pulmonary vasculature, results in a deleterious condition. More specifically, this condition increases the work load to the heart and may lead to heart failure.
- Methods of treating conditions relating to the malfunctioning of the heart valve specifically including valve incompetencies, mitral valve leakage and other heart failure conditions may be in various stages of development such as the extending of an elongate member transverse across a corresponding or affected heart chamber. Each end of the elongate member extends through a wall of the heart such as the septum wall and an oppositely disposed wall portion, wherein first and second anchoring members are connected to corresponding ends of the elongate member but are disposed external of the heart chamber. Connecting clips or the like are applied to the corresponding exterior ends of the elongate member, resulting in the papillary muscles within the chamber to be effectively repositioned. A predetermined force is applied to the heart itself and/or the affected portions of the heart chamber.
- Other specific treatments associated with mitral regurgitation sometimes may include the replacement of the mitral valve, resulting in traumatic and frequently dangerous surgical procedures being performed on a patient.
- Accordingly, there is a need in the medical arts for appropriate instrumentation and attendant methods of overcoming heart valve malfunctions, specifically including mitral regurgitation.
- The present invention is directed to an instrument assembly and attendant method for treating heart valve malfunction. In more specific terms, the instrumentation and method are specifically, but not exclusively, adapted for the treatment of mitral regurgitation. However, for purposes of clarity and in order to emphasize the versatility of the various embodiments of the present invention, the subject instrument assembly and method will be described generically regarding treatment of a predetermined heart valve. In addition, the present invention will be more specifically described in regard to a procedure involving correction of a prolapsing mitral valve leaflet, which may include the anterior mitral valve leaflet and/or the posterior valve leaflet correcting of mitral regurgitation.
- Accordingly, the instrument assembly of the present invention includes an introductory sheath formed of a material of sufficient rigidity to facilitate the penetration and passage through various portions of the heart and mitral valve. As such, the introductory sheath may be said to be formed of at least a “semi-rigid” material. However, this term is to be understood to include material having sufficient flexibility to be manipulated or “steered” through and/or along a predetermined path during the delivery of the sheath and associated components of the instrument assembly to predetermined portions of the heart. Moreover, in one preferred embodiment the sheath will be sufficiently maneuverable to pass through the atrial wall into interior portions of the heart such as the left atrium and left ventricle. In addition and as described in greater detail hereinafter, an introduction assembly and a delivery catheter will be used to facilitate the positioning the introductory sheath into the thoracic cavity and through the atrial wall or other preferred exterior locations of the heart wall.
- Additional structural operative features of the instrument assembly include the provision and utilization of at least one, or under required circumstances, more than one elongated chord formed of a biocompatible material and being at least partially flexible. The material from which the chord is formed should have sufficient and/or predetermined tensile strength to exert a predetermined tension on the predetermined, prolapsing valve leaflet as the chord extends between a corresponding portion of the heart wall, such as the ventricular wall, as also more fully described hereinafter. The chord is initially housed concentrically within the interior of the introductory sheath, wherein the sheath and the chord are concurrently movable relative to the heart as well as throughout a portion of the interior thereof. As set forth above, the introductory sheath is formed of a material having physical characteristics that allow it to be accurately manipulated so as to be steerable in such a manner that its tip can aim towards the different designated portions of the anterior or posterior mitral valve leaflets that are in the siege of the prolapse.
- Also, the exteriorly concentric introductory sheath is movable relative to and along the length of the chord so as to accommodate proper and intended placement and anchoring of the chord within the heart chamber. Therefore, the sheath is movable with the chord into and through predetermined portions of the heart chamber and movable relative to the chord after proper anchoring, securing and/or intended placement of the chord within the heart chamber. Accordingly, the instrument assembly of the present invention also includes an anchor secured to an outer or distal end of the chord. The anchor may also be sufficiently sharpened, pointed or otherwise configured to penetrate an intended heart valve leaflet, such as a prolapsing leaflet of the mitral valve. Further, the penetration and passage of the anchor, the chord, and the introductory sheath substantially through the predetermined valve leaflet may thereby be facilitated.
- When properly positioned, the anchor is structured to be secured to a substantially opposing portion of the heart wall, such as the ventricular wall associated with the left ventricle and/or the papillary muscles associated therewith. In order to assure secure anchoring of the distal end of the chord with the corresponding ventricular wall, a gripping structure may be operatively attached to a remainder of the anchor and disposable into an outwardly and/or radially extending orientation. When so disposed, the gripping structure, in combination with the remainder of the anchor, eliminates or significantly restricts the inadvertent detachment of the anchor, and the distal end of the chord attached thereto, from the corresponding ventricular wall portion. In at least one preferred embodiment of the present invention, the anchor and the gripping structure are disposed and applied so as to penetrate the corresponding portion of the ventricular wall but not extend there through. Therefore, the anchored relation of the gripping structure, anchor and the connected distal end of the chord may be defined by a penetration into the interior of the ventricular wall rather than a passage completely there through. Complications associated with sealing and exterior attachment of the chord to the exterior of the ventricular wall are thereby eliminated.
- As provided, the present invention further comprises a method of treating heart and valve malfunction utilizing the instrument as generally set forth above. Accordingly, the attendant method comprises, at least in more generic terms, the passing of a portion of the instrument assembly into an intended heart chamber and into penetrating relation to a predetermined valve leaflet, such as a prolapsing leaflet. The sheath, with the chord concentrically disposed on the interior thereof, is passed through the predetermined valve leaflet. Therefore, by virtue of the enclosed disposition of the chord, the chord and sheath will concurrently enter and extend through the predetermined valve leaflet. By manipulation and the application of a positioning force on the sheath, the sheath and the chord will extend across a corresponding heart chamber and into an anchored relation with a substantially opposing portion of the heart wall.
- Once the anchor and the connected distal end of the chord are secured to the opposing heart wall portion, the sheath, still concentrically mounted exteriorly of and in enclosing relation to the chord, is withdrawn from heart chamber in which the chord is anchored. More specifically, the sheath is withdrawn by moving relative to and back along the length of the anchored chord in a direction away from the anchor and connected distal end of the chord. The introductory sheath is further withdrawn back through the predetermined valve leaflet while the proximal portion of the chord remains within the valve leaflet. Once the sheath is disposed exteriorly of the valve leaflet and possibly on the exterior of the heart itself, a securing assembly is operatively disposed within the heart chamber in interconnecting relation between a proximal extremity of the chord and the predetermined valve leaflet.
- In more specific terms, the securing assembly may include a securing member, which will be mounted on or connected to a proximal portion of the chord and moved along the length thereof into a predetermined, interconnecting position relative to the prolapsing valve leaflet. The position of the securing member will be tailored to and disposed at the exact position needed to achieve correction of the mitral regurgitation, which may be determined by preoperative transoesopageal echography or other preoperative manner, to quantify the occurring mitral regurgitation preoperatively. The securing member then securely interconnects the proximal extremity of the chord to the predetermined valve leaflet and any excess length of the chord will be severed or detached from the proximal extremity of the chord, which is secured to the surface of the leaflet associated with the atrium. The chord is thereby properly tensioned between the opposing, interior corresponding wall portion of the heart and the predetermined valve leaflet so as to overcome the malfunction of the predetermined valve leaflet as explained in more specific details hereinafter.
- As emphasized throughout this description, the instrument assembly and attendant method of the present invention is specifically adapted for the treatment of mitral regurgitation. As such, the introductory sheath and the chord, substantially concurrently enter the atrial wall of the left atrium and pass into the interior thereof. Further, the sheath and the chord penetrate and are passed, substantially concurrently, through a prolapsing (flail) anterior or posterior leaflet of the mitral valve into the left ventricle of the heart chamber. Thereafter the sheath and chord are concurrently extended transversely across the left ventricle, wherein the anchor penetrates and is thereby secured in an anchored relation with a substantially opposing portion of the ventricular wall and/or corresponding papillary muscles. The distal end of the chord is connected to the anchor and is thereby secured in an anchored relation to the ventricular wall, by virtue of the penetrating anchor.
- Once the distal end of the chord and anchor are in the anchored relation to the ventricular wall, the sheath is withdrawn back along the length of the chord, away from the anchor and the ventricular wall to which the distal portion of the chord is secured. Moreover, the introductory sheath continues to travel back along the length of the chord through the prolapsing anterior or posterior mitral valve leaflet to a location at least exterior to the leaflet, such as within the left atrium and possibly exteriorly of the heart itself.
- A securing assembly is then operatively associated with the instrument and is movably disposed along the length of a proximal portion of the chord. In even more specific terms, the movement of the securing assembly and its associated securing member are disposed into an interconnecting position between a proximal extremity of the chord and the mitral valve leaflet penetrated by the chord. As indicated above, proper tensioning is thereby placed on the prolapsing mitral valve leaflet in order to restore a sufficient surface of coaptation between its counterpart, opposing leaflet and maintain the suppressed leaflet in an operative position sufficient to overcome the mitral regurgitation.
- These and other objects, features and advantages of the present invention will become clearer when the drawings as well as the detailed description are taken into consideration.
- For a fuller understanding of the nature of the present invention, reference should be had to the following detailed description taken in connection with the accompanying drawings in which:
-
FIG. 1 is a perspective view of one preferred embodiment of the instrument assembly of the present invention used in the treatment of heart valve malfunction. -
FIG. 1A is a perspective view of the instrument assembly of the embodiment ofFIG. 1 in an initially introductory position. -
FIGS. 2 through 9 are schematic representations of successive steps in the attendant method of utilizing and applying the instrument assembly of the embodiment ofFIGS. 1 and 1A specifically for the treatment and correction of mitral regurgitation. - Like reference numerals refer to like parts throughout the several views of the drawings.
- As represented in the accompanying drawings and with specific reference to
FIGS. 1 and 1A , the instrument assembly of the present invention is schematically and generally indicated as 10 and is used for the treatment of heart valve malfunction generally and more specifically for the treatment of mitral regurgitation. As such, theinstrument assembly 10 includes an elongated delivery catheter ortube 12 having a hollow interior and structured to deliver operative portions of theinstrument assembly 10 to the treatment site within the heart of a patient. As such, the elongated delivery catheter ortube 12 is dimensioned and configured to enter the chest cavity through appropriate introduction instrumentation. Thedelivery tube 12 is formed of a material and/or includes positioning structure or linkage incorporated therein which facilitates the maneuvering or steering thereof to a point at least generally exterior the heart and more specifically the atrial wall of the left atrium. However, the at least semi-rigid material of thedelivery tube 12 should be sufficient to also facilitate proper manipulation so as to position or “steer” the remainder of theinstrument assembly 10 to the intended location within the interior thereof, as well as facilitate penetration of and anchoring to intended tissue portions. - The
instrument assembly 10 also includes anintroductory sheath 14 movable within thedelivery tube 12 and an elongatedflexible material chord 16. Theintroductory sheath 14 is concentrically and movably enclosed within thedelivery tube 12 and thesheath 14 is movably disposed concentrically about thechord 16. It is emphasized thatFIG. 1 represents a completely assembledinstrument assembly 10. However, as will be described in detail with the schematic representations ofFIGS. 1 through 9 , the various portions of theinstrument assembly 10 are used in successive steps to accomplish installation relative to the affected portions of the heart valve being treated. - Accordingly, the
instrument assembly 10 further includes the elongatedflexible material chord 16 which may be formed of a synthetic, biocompatible material. Ananchor 18 is fixedly secured to the outer or distal end of thechord 16 and is movable therewith relative to theintroductory sheath 14. As clearly represented inFIG. 1A chord 16 is at least initially enclosed concentrically within the interior of theintroductory sheath 14, wherein thesheath 14 is movable along the length of thechord 16. Further, the sheath includes an opendistal end 14′ serving to at least partially encloses or be registered alignment with theanchor 18. Therefore,FIG. 1A represents cooperative portions of theinstrument assembly 10 at least upon initial entry of theintroductory sheath 14 andanchor 18 into the interior of theheart 30, as specifically described in detail inFIGS. 2 through 9 , hereinafter described. - Therefore, with further regard to
FIG. 1A , the positioning of theanchor 18, theintroductory sheath 14 and thechord 16 is such that thechord 16 is disposed within the interior of theintroductory sheath 14. Further, theanchor 18 is disposed at least partially within and/or in an exposed relation to the opendistal end 14′ of thesheath 14. In addition, theanchor 18 has a sharpened, pointed or other appropriate configuration for penetrating portions of the heart. Theanchor 18 may also include a grippingstructure 20 which may be initially disposed in a collapsed position when theanchor 18 is in registry with thedistal opening 14′ of thesheath 14. However, upon removal or exposure of theanchor 18 and a length of thechord 16 from an interior of thesheath 14, the grippingstructure 20 may include an inherent bias causing it to expand outwardly and/or radially from the remainder of theanchor 18. This grippingstructure 20 is provided to facilitate a secure engagement of theanchor 18 with predetermined heart wall portions, when theinstrument assembly 10 is properly applied in the treatment of the heart valve malfunction. - With further reference to
FIG. 1 the assembled representation of theinstrument assembly 10 further includes the provision of a securingmember 22 which may travel along the length of thechord 16. The securing member may be forcibly positioned into an intended interconnecting location relative to a heart valve leaflet in order to accomplish a secure attachment of thechord 16 to the leaflet as will be explained in greater detail hereinafter. Such an interconnecting placement of the securingmember 22 relative to both thechord 16 and the affected valve leaflet serves to establish and maintain a sufficient tension and/or positioning force on the predetermined valve leaflet to suppress movement thereof, as explained hereinafter with regard toFIGS. 2 through 9 . - As schematically represented in
FIGS. 2 through 9 , the heart is generally indicated as 30 and includes the representative portions including theleft atrium 32, theleft ventricle 34 and themitral valve 36, including the anterior and posteriormitral valve leaflets left ventricle 34 is at least partially bordered or surrounded byventricular wall 40 which may be directly associated with corresponding papillary muscles (not shown) facilitating the proper positioning of themitral valve leaflets - For purposes of clarity,
FIGS. 2-9 schematically represent theinstrument assembly 10 used on theanterior leaflet 38 of themitral valve 30 in order to treat and correct mitral regurgitation. However, it is emphasized theinstrument assembly 10 and the attendant method of the present invention may be applied to an anterior and/or the posterior prolapsing leaflet in the manner described herein, in correcting a mitral regurgitation condition of the heart. Moreover, while the various embodiments of the present invention are described using asingle chord 16, a plurality ofchords 16 may be used with the cooperative instrument components of theinstrument assembly 10. - With initial reference to
FIGS. 2 and 3 , theinstrument assembly 10 is introduced into the interior of theheart 30 and more specifically into theleft atrium 32, through theatrium wall 33, using anappropriate introduction assembly 42. Therefore, theintroductory sheath 14 and thechord 16 located concentrically within thesheath 14 will concurrently pass through theatrial wall 33 of the heart into theleft atrium 32, as it is directed towards theanterior leaflet 38 of themitral valve 36. It should be further noted that theanchor 18 is at least initially in the position generally represented inFIG. 1A . Due to its predetermined configuration theanchor 18 will serve to approach and penetrate theanterior leaflet 38 of themitral valve 36 as clearly represented inFIG. 3 . - In addition, the penetration of the
anterior leaflet 38 initially by theanchor 18 will facilitate the penetration and passage, substantially concurrently, of thechord 16 and theintroductory sheath 14 through theanterior leaflet 38 as schematically represented. As further represented inFIG. 3 , a continued force will be applied to theintroductory sheath 14 causing thesheath 14 and interiorly disposedchord 16, as well as theanchor 18 to continue concurrent passage through theanterior valve leaflet 38 until theanchor 18 reaches, penetrates and is secured to theventricular wall 40 and/or correspondingly disposed papillary muscles associated therewith. - As best represented in
FIGS. 4 and 5 , once theanchor 18 is secured to theventricular wall 40 and/or the corresponding papillary muscles, the distal end of thechord 16 will be affixed to theventricular wall 40 and remain in place as theintroductory sheath 14 is withdrawn back along the length of thechord 16, as indicated by the directional arrows. As theintroductory sheath 14 is withdrawn back along the length of thechord 16, the aforementionedgripping structure 20 will have been expanded into a gripping orientation. When the grippingstructure 20 is so oriented, theanchor 18 and the distal end of thechord 16 connected thereto will be reliably anchored or connected to theventricular wall 40. Continued withdrawal of theintroductory sheath 14 will result in its passage back through the initially penetrated and suppressedmitral valve leaflet 38, as clearly represented inFIG. 5 . As such, the majority of the length of thechord 16 will thereby be exposed and maintained in the represented position within the left ventricle and between theventricular wall 40 and the penetrated (suppressed)leaflet 38, while theintroductory sheath 14 passes back through theintroduction assembly 42 and out of the interior of theleft atrium 32, through theatrium wall 33. Therefore, theproximal portion 16′ of thechord 16 remains in place, within theleft atrium 32, and may serve effectively as a guide or otherwise facilitate the placement of the securingmember 22, as represented inFIGS. 6 through 9 . - More specifically, once the
introductory sheath 14 is removed from theleft atrium 32, through theintroduction assembly 42, the securing assembly, including securingmember 22, will move along the length of thechord 16 as it is introduced into theleft atrium 32 such as through the atrium wall via, theintroduction assembly 42. As schematically represented, the securingmember 22 will be forced, moved, positioned, etc. along the proximal portion orlength 16′ of thechord 16 by any appropriate technique and/or appropriate positioning instrument/device, which may be incorporated or operatively associated with thechord 16. Positioning of the securingmember 22 will continue until it is disposed in engaging, interconnecting and at least partially protective or sealing engagement with an exterior surface portion of the suppressed anteriormitral valve leaflet 38 located within theleft atrium 32. The position of the securingmember 22 will be disposed in the exact position, on and along the length of thechord 16 needed to position and or suppress movement of theleaflet 38 to achieve correction of the mitral regurgitation. Such exact positioning may be determined by preoperative transoesopageal echography or other preoperative manner to quantify online mitral regurgitation preoperatively. - With further regard to the positioning of the securing
member 22 into the interconnecting relation between the proximal extremity ofchord 16 and theanterior leaflet 38. One embodiment may also include a guiding element orsleeve 25, as represented inFIG. 1 . When utilized, theelement 25 will be disposed at a predetermined position along the length on theartificial chord 16 and be mounted concentrically about and/or along a portion of thechord 16. As applied, the guidingelement 25 may assume and or be at least partially defined by a variety of different structures, devices and/or mechanisms other than, but possibly including, the schematically represented sleeve. Accordingly, the guiding element is operative to accurately center or otherwise dispose the securingmember 22 in sealing and/or covering relation to the aperture or area where thechord 16 remains in its extended position through theanterior leaflet 38. Further, the securingmember 22 securely connects theproximal extremity 16″ of thechord 16 to thevalve leaflet 38 and any excess length of theproximal portion 16′ of thechord 16 will be severed or detached from theextremity 16″ of thechord 16 and the securingmember 22, which interconnects theproximal extremity 16″ to the “exterior” surface of theleaflet 38 exposed to theleft atrium 32. - With continued reference to
FIGS. 5 through 8 , manipulation of the instrument of theassembly 10, such as by medical personnel manipulating thedelivery catheter 12 causes a severing of the proximal extremity from a remainder of thechord 16. As a result, the securingmember 22 serves to securely connect and fasten thechord 16 to the exterior of theanterior leaflet 38, disposed within theleft atrium 32. Upon a secure connection of the securingmember 22 to the exterior side or surface of theanterior leaflet 38, theintroductory sheath 14 passes back through theintroduction assembly 42 so as to exit theleft atrium 32 and the remainder of the heart. Thereafter, theintroduction assembly 42 is also removed from its initial operative position. - Therefore, as represented in
FIG. 9 theheart 30 is represented with thesynthetic chord 16 properly anchored between theventricular wall 40 and the penetratedanterior leaflet 38. In this position, proper tensioning or positioning forces are applied to theanterior leaflet 38 causing it to be positioned in a manner which effectively overcomes mitral regurgitation, as set forth above. - Since many modifications, variations and changes in detail can be made to the described preferred embodiment of the invention, it is intended that all matters in the foregoing description and shown in the accompanying drawings be interpreted as illustrative and not in a limiting sense. Thus, the scope of the invention should be determined by the appended claims and their legal equivalents.
- Now that the invention has been described,
Claims (28)
1. An instrument assembly for treating heart valve malfunction, said instrument assembly comprising:
at least one elongated chord and an introductory sheath, said sheath at least initially disposed in enclosing relation to said one chord and movable with said chord and along the length thereof,
said sheath and said one chord cooperatively structured to concurrently enter the heart chamber through the heart wall and penetrate and pass through a predetermined heart valve leaflet,
an anchor connected to a distal end of said one chord and disposable into an anchored relation with the heart wall substantially oppositely disposed to the predetermined valve leaflet,
a securing assembly connectable to a proximal extremity of said one chord in an interconnecting position between said one chord and the predetermined valve leaflet, and
said anchored relation of said anchor and said interconnecting position of said securing assembly collectively defining an operative length of one said chord within the heart chamber and a tensioning of the predetermined valve leaflet sufficient to restrict prolapsing of the predetermined valve leaflet, by said one chord.
2. An instrument assembly as recited in claim 1 wherein said interconnecting position comprises said securing assembly disposed in securing relation between said proximal extremity of said one chord and an exterior surface exposed to the left atrium of the predetermined valve leaflet.
3. An instrument assembly as recited in claim 1 wherein the predetermined valve leaflet comprises a prolapsing one of the anterior mitral valve leaflet and posterior mitral valve leaflet.
4. An instrument assembly as recited in claim 1 wherein said securing assembly comprises a securing member movably mounted on and extendable along the length of said one chord into said interconnecting position.
5. An instrument assembly as recited in claim 4 wherein said securing assembly further comprises a sleeve connected to said securing member, said sleeve concentrically mounted on and positionable along the length of said one chord with said securing member into said interconnecting position.
6. An instrument assembly as recited in claim 5 wherein said interconnecting position further comprises said sleeve disposed through the predetermined valve leaflet concurrently to said securing member being disposed in securing relation between said proximal extremity of said one chord and the predetermined valve leaflet.
7. An instrument assembly as recited in claim 1 wherein said anchor comprises an outer extremity comprising a configuration sufficient to penetrate the opposing heart wall portion.
8. An instrument assembly as recited in claim 7 wherein said outer extremity is disposable in penetrating relation to the predetermined valve leaflet prior to a chord securing relation with the opposing heart wall portion.
9. An instrument assembly as recited in claim 7 wherein said sheath comprises an open distal end dimensioned to facilitate disposition of said anchor into a penetrating orientation to the predetermined valve leaflet and subsequently, the opposing heart wall portion.
10. An instrument assembly as recited in claim wherein said anchor comprises a gripping structure disposed laterally outward from said outer extremity of said anchor; said gripping structure structured to define a secure connection of said anchor with the opposing heart wall portion.
11. An instrument assembly as recited in claim 10 wherein said gripping structure is expandable radially outward from said outer extremity of said anchor.
12. An instrument assembly as recited in claim wherein said anchor comprises a gripping structure disposed laterally outward from said outer extremity of said anchor; said gripping structure structured to define a secure connection of said anchor with the opposing heart wall.
13. A method of treating mitral valve regurgitation using the instrument assembly as recited in claim 1 , the method comprising:
introducing the sheath and at least one chord into the chamber of the heart through the atrium wall thereof;
passing the sheath and one chord substantially concurrently through at least one mitral valve leaflet in the siege of prolapse and there from into the left ventricle of the heart chamber,
extending the sheath and one chord transversely across the left ventricle and securing the anchor into an anchored relation with a substantially opposing portion of the ventricular wall of the heart,
withdrawing the sheath back along the length of the anchored one chord from the ventricular wall and back through the one mitral valve leaflet, and
securing the securing assembly along the length of the one chord into an interconnecting position between a proximal extremity of the one chord and the one mitral valve leaflet.
14. A method as recited in claim 13 disposing the securing assembly along the length of the one chord into the interconnecting position with an exterior of the one mitral valve leaflet which is exposed to the left atrium.
15. A method as recited in claim 13 comprising passing the sheath and one chord substantially concurrently through the anterior mitral valve leaflet in the siege of prolapse and there from into the left ventricle of the heart chamber.
16. A method as recited in claim 13 comprising passing the sheath and one chord substantially concurrently through the posterior mitral valve leaflet in the siege of prolapse and there from into the left ventricle of the heart chamber.
17. A method as recited in claim 13 comprising disconnecting a remaining distal portion of the one chord, extending between the securing assembly and the atrium wall, subsequently to securing the securing assembly in the interconnecting position.
18. A method of treating heart valve malfunction comprising:
passing an instrument into the heart chamber and into penetrating relation to a predetermined valve leaflet under the siege of prolapse,
passing the instrument through the predetermined valve leaflet,
extending at least one chord of the instrument from the predetermined valve leaflet across the heart chamber into anchored relation with a portion of the heart wall substantially opposing the predetermined valve leaflet,
withdrawing a sheath of the instrument back along a length of the anchored one chord from the opposing portion of the heart wall and back through the predetermined valve leaflet, and
securing a corresponding proximal extremity of the one chord to the predetermined valve leaflet.
19. A method as recited in claim 18 comprising disposing an anchor of the instrument into a griping orientation when in the anchored relation with the opposing portion of the heart wall.
20. A method as recited in claim 19 further comprising expanding the anchor into the gripping orientation with the opposing portion of the heart wall.
21. A method as recited in claim 19 further comprising defining the gripping orientation of the anchor portion as a penetrating engagement with an interior portion of the ventricular wall.
22. A method as recited in claim 21 further comprising tensioning the one chord between the ventricular wall and the predetermined valve leaflet by securing the corresponding proximal extremity of the one chord to an exterior of the predetermined valve leaflet.
23. A method as recited in claim 18 further comprising establishing an operative length of said one chord between the predetermined valve leaflet and the opposing portion of the heart wall to define a tensioning of the predetermined valve leaflet sufficient to restrict prolapsing of the predetermined valve leaflet, by the one chord.
24. A method as recited in claim 18 comprising treating mitral valve regurgitation by entering the heart through the atrial wall into the left atrium and penetrating the predetermined mitral valve leaflet under the siege of prolapse with a distal portion of the one chord and passing the one chord through the mitral valve leaflet and transversely across the left ventricle and disposing an anchor, secured to the distal end of the one chord, into anchored relation with an oppositely disposed portion of the ventricular wall.
25. A method as recited in claim 24 comprising positioning the anchor into a gripping orientation on the interior of the heart chamber by penetrating interior portions of the ventricular wall.
26. A method as recited in claim 25 further defining the gripping orientation by expanding the anchor into penetrating engagement with the interior portions of the papillary muscle of the ventricular wall.
27. A method as recited in claim 24 further comprising tensioning the one chord between the penetrated portion of the ventricular wall and the one mitral valve leaflet by securing a proximal extremity of the one chord to the one mitral valve leaflet.
28. A method as recited in claim 27 further comprising establishing an operative length of said one chord between the predetermined mitral valve leaflet and penetrated portion of the ventricular wall to define a tensioning of the predetermine valve leaflet sufficient to restrict prolapsing of the predetermined mitral valve leaflet, by the one chord.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/691,087 US20140142689A1 (en) | 2012-11-21 | 2012-11-30 | Device and method of treating heart valve malfunction |
US13/967,647 US10159571B2 (en) | 2012-11-21 | 2013-08-15 | Device and method of treating heart valve malfunction |
JP2015544111A JP2015535465A (en) | 2012-11-21 | 2013-11-20 | Apparatus and method for treating heart valve failure |
AU2013348100A AU2013348100C1 (en) | 2012-11-21 | 2013-11-20 | Device and method of treating heart valve malfunction |
PCT/US2013/070972 WO2014081809A2 (en) | 2012-11-21 | 2013-11-20 | Device and method of treating heart valve malfunction |
EP13856513.0A EP2922502B1 (en) | 2012-11-21 | 2013-11-20 | Device for treating heart valve malfunction |
CA2891356A CA2891356A1 (en) | 2012-11-21 | 2013-11-20 | Device and method of treating heart valve malfunction |
IL238933A IL238933A0 (en) | 2012-11-21 | 2015-05-20 | Device and method of treating heart valve malfunction |
JP2018005752A JP2018061855A (en) | 2012-11-21 | 2018-01-17 | Device and method of treating heart valve malfunction |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261729152P | 2012-11-21 | 2012-11-21 | |
US13/691,087 US20140142689A1 (en) | 2012-11-21 | 2012-11-30 | Device and method of treating heart valve malfunction |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/967,647 Continuation-In-Part US10159571B2 (en) | 2012-11-21 | 2013-08-15 | Device and method of treating heart valve malfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140142689A1 true US20140142689A1 (en) | 2014-05-22 |
Family
ID=50728681
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/691,087 Abandoned US20140142689A1 (en) | 2012-11-21 | 2012-11-30 | Device and method of treating heart valve malfunction |
US13/967,647 Active 2033-06-14 US10159571B2 (en) | 2012-11-21 | 2013-08-15 | Device and method of treating heart valve malfunction |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/967,647 Active 2033-06-14 US10159571B2 (en) | 2012-11-21 | 2013-08-15 | Device and method of treating heart valve malfunction |
Country Status (7)
Country | Link |
---|---|
US (2) | US20140142689A1 (en) |
EP (1) | EP2922502B1 (en) |
JP (2) | JP2015535465A (en) |
AU (1) | AU2013348100C1 (en) |
CA (1) | CA2891356A1 (en) |
IL (1) | IL238933A0 (en) |
WO (1) | WO2014081809A2 (en) |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140114390A1 (en) * | 2010-01-22 | 2014-04-24 | 4Tech Inc. | Tricuspid valve repair using tension |
US20150025312A1 (en) * | 2011-08-09 | 2015-01-22 | Didier De Canniere | Introductory assembly and method for inserting intracardiac instruments |
US20150045878A1 (en) * | 2006-10-04 | 2015-02-12 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US20150148692A1 (en) * | 2013-11-22 | 2015-05-28 | On-X Life Technologies, Inc. | Chordal Sizer |
US20160120535A1 (en) * | 2014-10-29 | 2016-05-05 | Smith & Nephew, Inc. | Modular tissue repair kit and devices and method related thereto |
WO2016126699A1 (en) * | 2015-02-02 | 2016-08-11 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
US9693865B2 (en) | 2013-01-09 | 2017-07-04 | 4 Tech Inc. | Soft tissue depth-finding tool |
US9801720B2 (en) | 2014-06-19 | 2017-10-31 | 4Tech Inc. | Cardiac tissue cinching |
WO2017210434A1 (en) * | 2016-06-01 | 2017-12-07 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US9877833B1 (en) | 2016-12-30 | 2018-01-30 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US9907547B2 (en) | 2014-12-02 | 2018-03-06 | 4Tech Inc. | Off-center tissue anchors |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
CN108697418A (en) * | 2015-11-02 | 2018-10-23 | 马里兰大学巴尔的摩分校 | Distal side anchoring device and method for mitral valve reparation |
US10206673B2 (en) | 2012-05-31 | 2019-02-19 | 4Tech, Inc. | Suture-securing for cardiac valve repair |
US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
USD853561S1 (en) * | 2018-02-16 | 2019-07-09 | Chengjun Guo | Implantation device |
US20190254816A1 (en) * | 2018-02-22 | 2019-08-22 | Medtronic Vascular, Inc. | Prosthetic heart valve delivery systems and methods |
US10405978B2 (en) | 2010-01-22 | 2019-09-10 | 4Tech Inc. | Tricuspid valve repair using tension |
US10543090B2 (en) | 2016-12-30 | 2020-01-28 | Pipeline Medical Technologies, Inc. | Neo chordae tendinae deployment system |
US20200222186A1 (en) * | 2019-01-16 | 2020-07-16 | Neochord, Inc. | Transcatheter methods for heart valve repair |
US10799356B2 (en) | 2017-09-12 | 2020-10-13 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
US10925731B2 (en) | 2016-12-30 | 2021-02-23 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US20220142778A1 (en) * | 2019-01-28 | 2022-05-12 | Vesalius Cardiovascular Inc. | Apparatus for use in repairing mitral valves and method of use thereof |
US11696828B2 (en) | 2016-12-30 | 2023-07-11 | Pipeline Medical Technologies, Inc. | Method and apparatus for mitral valve chord repair |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
GB2536538B (en) | 2014-09-17 | 2018-07-18 | Cardiomech As | Anchor for implantation in body tissue |
JP7006940B2 (en) | 2016-01-29 | 2022-01-24 | ニオバスク ティアラ インコーポレイテッド | Artificial valve to avoid blockage of outflow |
WO2018090148A1 (en) | 2016-11-21 | 2018-05-24 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
EP3672530A4 (en) | 2017-08-25 | 2021-04-14 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
JP7260930B2 (en) | 2018-11-08 | 2023-04-19 | ニオバスク ティアラ インコーポレイテッド | Ventricular deployment of a transcatheter mitral valve prosthesis |
EP3946163A4 (en) | 2019-04-01 | 2022-12-21 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
WO2020210652A1 (en) | 2019-04-10 | 2020-10-15 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
CA3140925A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
WO2020257643A1 (en) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
CN113662714A (en) * | 2021-08-30 | 2021-11-19 | 上海汇禾医疗器械有限公司 | Clamping device |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100042147A1 (en) * | 2008-08-14 | 2010-02-18 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
US20100179574A1 (en) * | 2009-01-14 | 2010-07-15 | James Longoria | Synthetic chord |
US20110029071A1 (en) * | 2007-12-20 | 2011-02-03 | Amnon Zlotnick | Elongated body for deployment in a coronary sinus |
US8147542B2 (en) * | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
WO2013036742A1 (en) * | 2011-09-09 | 2013-03-14 | Emory University | Systems, devices and methods for repair of heart valve lesions |
US8408214B2 (en) * | 2010-07-08 | 2013-04-02 | Benjamin Spenser | Method for implanting prosthetic valve |
US8758393B2 (en) * | 2007-10-18 | 2014-06-24 | Neochord, Inc. | Minimally invasive repair of a valve leaflet in a beating heart |
US8790394B2 (en) * | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
Family Cites Families (465)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3587567A (en) | 1968-12-20 | 1971-06-28 | Peter Paul Schiff | Mechanical ventricular assistance assembly |
IT1155105B (en) | 1982-03-03 | 1987-01-21 | Roberto Parravicini | PLANT DEVICE TO SUPPORT THE MYOCARDIUM ACTIVITY |
US4690134A (en) | 1985-07-01 | 1987-09-01 | Snyders Robert V | Ventricular assist device |
US5201742A (en) | 1991-04-16 | 1993-04-13 | Hasson Harrith M | Support jig for a surgical instrument |
GR930100244A (en) | 1992-06-30 | 1994-02-28 | Ethicon Inc | Flexible endoscopic surgical port |
US20020095164A1 (en) * | 1997-06-26 | 2002-07-18 | Andreas Bernard H. | Device and method for suturing tissue |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5591170A (en) | 1994-10-14 | 1997-01-07 | Genesis Orthopedics | Intramedullary bone cutting saw |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6540693B2 (en) | 1998-03-03 | 2003-04-01 | Senorx, Inc. | Methods and apparatus for securing medical instruments to desired locations in a patients body |
US6405491B1 (en) | 1999-04-22 | 2002-06-18 | Hill-Rom Services, Inc. | Modular patient room |
US6328757B1 (en) | 1999-04-23 | 2001-12-11 | Robert G. Matheny | Device and method for performing surgery without impeding organ function |
US6206907B1 (en) | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6692916B2 (en) | 1999-06-28 | 2004-02-17 | Source Precision Medicine, Inc. | Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
US8062675B2 (en) | 1999-07-07 | 2011-11-22 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
US6592609B1 (en) * | 1999-08-09 | 2003-07-15 | Bonutti 2003 Trust-A | Method and apparatus for securing tissue |
US20040102804A1 (en) | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US6551303B1 (en) | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6641592B1 (en) * | 1999-11-19 | 2003-11-04 | Lsi Solutions, Inc. | System for wound closure |
US6462169B1 (en) | 1999-11-30 | 2002-10-08 | Poly-Med, Inc. | Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
US8217304B2 (en) | 2001-03-29 | 2012-07-10 | Gsi Group Corporation | Methods and systems for thermal-based laser processing a multi-material device |
US7145191B1 (en) | 2000-03-31 | 2006-12-05 | National Semiconductor Corporation | P-channel field-effect transistor with reduced junction capacitance |
DE60022475T2 (en) | 2000-04-19 | 2006-06-14 | Radi Medical Systems Ab Uppsal | Intra-arterial occlusion device |
JP3844661B2 (en) | 2000-04-19 | 2006-11-15 | ラディ・メディカル・システムズ・アクチェボラーグ | Intra-arterial embolus |
US6902522B1 (en) | 2000-06-12 | 2005-06-07 | Acorn Cardiovascular, Inc. | Cardiac disease treatment and device |
US6482146B1 (en) | 2000-06-13 | 2002-11-19 | Acorn Cardiovascular, Inc. | Cardiac disease treatment and device |
DE10029834A1 (en) | 2000-06-16 | 2002-01-03 | Infineon Technologies Ag | Method for transferring data between devices connected via a bus, and device connectable via a bus to other devices |
US6840246B2 (en) | 2000-06-20 | 2005-01-11 | University Of Maryland, Baltimore | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
WO2002004064A1 (en) | 2000-07-12 | 2002-01-17 | Oma Medical Technologies, Inc. | Minimally invasive bypass system and related methods |
WO2002022687A2 (en) | 2000-09-15 | 2002-03-21 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Viral chemokine-tumur antigen fusion proteins |
US6508828B1 (en) | 2000-11-03 | 2003-01-21 | Radi Medical Systems Ab | Sealing device and wound closure device |
ES2173073T3 (en) | 2000-11-03 | 2002-10-16 | Radi Medical Systems | DEVICE OF SUTURE AND CLOSURE OF WOUNDS. |
US6616596B1 (en) | 2000-11-28 | 2003-09-09 | Abiomed, Inc. | Cardiac assistance systems having multiple layers of inflatable elements |
ATE303100T1 (en) | 2001-01-12 | 2005-09-15 | Radi Medical Systems | ARTERY WALL CLOSURE DEVICE PROVIDED WITH A POSITION INDICATOR |
US6890295B2 (en) | 2002-10-31 | 2005-05-10 | Medtronic, Inc. | Anatomical space access tools and methods |
US6786898B2 (en) | 2003-01-15 | 2004-09-07 | Medtronic, Inc. | Methods and tools for accessing an anatomic space |
AU2002240269B2 (en) | 2001-02-07 | 2007-06-21 | The United States Government As Represented By The Department Of Veteran's Affairs | Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
US6537290B2 (en) | 2001-03-05 | 2003-03-25 | Edwards Lifesciences Corporation | Sealing access cannula system |
US6699240B2 (en) | 2001-04-26 | 2004-03-02 | Medtronic, Inc. | Method and apparatus for tissue ablation |
ES2202269T3 (en) | 2001-05-03 | 2004-04-01 | Radi Medical Systems Ab | GUIDE TOOL FOR WOUND CLOSURE. |
JP4267867B2 (en) | 2001-05-03 | 2009-05-27 | ラディ・メディカル・システムズ・アクチェボラーグ | Wound occlusion element guide device |
ES2223679T3 (en) | 2001-05-09 | 2005-03-01 | Radi Medical Systems Ab | SHUTTER OF AN ARTERIAL PERFORATION. |
JP4159805B2 (en) | 2001-06-15 | 2008-10-01 | ラディ・メディカル・システムズ・アクチェボラーグ | Pushing mechanism for closing method |
ES2236170T3 (en) | 2001-06-15 | 2005-07-16 | Radi Medical Systems Ab | MACHINING MECHANISM. 3. |
US6893460B2 (en) | 2001-10-11 | 2005-05-17 | Percutaneous Valve Technologies Inc. | Implantable prosthetic valve |
US8175680B2 (en) | 2001-11-09 | 2012-05-08 | Boston Scientific Scimed, Inc. | Systems and methods for guiding catheters using registered images |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
PL401638A1 (en) | 2002-03-13 | 2013-05-27 | Array Biopharma Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
US7691461B1 (en) | 2002-04-01 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Hybrid stent and method of making |
JP2006500910A (en) | 2002-04-18 | 2006-01-12 | アキュイティ ファーマシューティカルズ、インク. | Means and method for specifically regulating CNS and eye target gene and identification method thereof |
DK1507554T3 (en) | 2002-05-10 | 2011-11-21 | Agennix Inc | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
US8246753B2 (en) | 2002-05-13 | 2012-08-21 | Aero Jet Wash Llc | Gaspath cleaning system |
US6790214B2 (en) | 2002-05-17 | 2004-09-14 | Esophyx, Inc. | Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method |
US7041309B2 (en) | 2002-06-13 | 2006-05-09 | Neuropro Technologies, Inc. | Spinal fusion using an HMG-CoA reductase inhibitor |
US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US20040034386A1 (en) | 2002-08-19 | 2004-02-19 | Michael Fulton | Aneurysm stent |
EP2380900A1 (en) | 2002-09-23 | 2011-10-26 | E. I. du Pont de Nemours and Company | Isolation and use of ryanodine receptors |
EP1565844A4 (en) | 2002-11-11 | 2007-03-07 | Transparensee Systems Inc | Search method and system and systems using the same |
US20050008676A1 (en) | 2002-12-19 | 2005-01-13 | Yongxing Qiu | Medical devices having antimicrobial coatings thereon |
US8924049B2 (en) | 2003-01-06 | 2014-12-30 | General Electric Company | System and method for controlling movement of vehicles |
US6960220B2 (en) | 2003-01-22 | 2005-11-01 | Cardia, Inc. | Hoop design for occlusion device |
US20120276021A1 (en) | 2003-03-12 | 2012-11-01 | Danisco Us Inc. | Use of repeat sequence protein polymers in personal care compositions |
CA2519461C (en) * | 2003-03-26 | 2012-05-29 | Tyco Healthcare Group Lp | Energy stored in spring with controlled release |
WO2004091419A2 (en) | 2003-04-08 | 2004-10-28 | Wasielewski Ray C | Use of micro-and miniature position sensing devices for use in tka and tha |
US7330440B1 (en) | 2003-05-20 | 2008-02-12 | Cisco Technology, Inc. | Method and apparatus for constructing a transition route in a data communications network |
CA2528299A1 (en) | 2003-06-11 | 2005-01-06 | Furry Brothers, Llc | Systems and methods for performing inspections and detecting chemical leaks using an infrared camera system |
US8725246B2 (en) | 2003-07-23 | 2014-05-13 | Eleanor Schuler | Method and system for modulating eating behavior by means of neuro-electrical coded signals |
US8066973B2 (en) | 2003-09-05 | 2011-11-29 | The Ohio State University Research Foundation | Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
US8133500B2 (en) | 2003-12-04 | 2012-03-13 | Kensey Nash Bvf Technology, Llc | Compressed high density fibrous polymers suitable for implant |
CN1917876A (en) | 2003-12-16 | 2007-02-21 | Cns生物有限公司 | Methods and compositions |
US20050149108A1 (en) | 2003-12-17 | 2005-07-07 | Microvention, Inc. | Implant delivery and detachment system and method |
US8223632B2 (en) | 2003-12-23 | 2012-07-17 | At&T Intellectual Property I, L.P. | Method and system for prioritized rerouting of logical circuit data in a data network |
US7431726B2 (en) * | 2003-12-23 | 2008-10-07 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US8048067B2 (en) | 2003-12-24 | 2011-11-01 | The Regents Of The University Of California | Tissue ablation with irreversible electroporation |
US7923109B2 (en) | 2004-01-05 | 2011-04-12 | Board Of Regents, The University Of Texas System | Inorganic nanowires |
DE102004002831B4 (en) | 2004-01-13 | 2010-06-17 | SSI Schäfer PEEM GmbH | Picking station and method for picking with a light grid |
US7445596B2 (en) | 2004-01-29 | 2008-11-04 | Cannuflow, Inc. | Atraumatic arthroscopic instrument sheath |
BRPI0508049B8 (en) | 2004-02-26 | 2016-10-11 | Cameron Systems Ireland Ltd | submerged flow interface equipment connection system |
US8152810B2 (en) | 2004-11-23 | 2012-04-10 | Jackson Roger P | Spinal fixation tool set and method |
US20070265643A1 (en) | 2004-03-23 | 2007-11-15 | Beane Richard M | Apparatus and method for suturelessly connecting a conduit to a hollow organ |
JP4960220B2 (en) | 2004-04-19 | 2012-06-27 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Ablation device having sensor structure |
US7641686B2 (en) | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
WO2005111241A2 (en) | 2004-05-07 | 2005-11-24 | Applera Corporation | Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
US20060049234A1 (en) | 2004-05-21 | 2006-03-09 | Flak Richard A | Friction stirring and its application to drill bits, oil field and mining tools, and components in other industrial applications |
US8258198B2 (en) | 2004-05-28 | 2012-09-04 | Air Products And Chemicals, Inc. | Fast demold/extended cream time polyurethane formulations |
EP1773239B1 (en) | 2004-07-15 | 2010-03-31 | Micardia Corporation | Shape memory devices for reshaping heart anatomy |
JP2008511672A (en) | 2004-08-30 | 2008-04-17 | セレゲン,インコーポレーテッド | Cultured three-dimensional tissue and use thereof |
WO2006027567A2 (en) | 2004-09-07 | 2006-03-16 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
US20060135962A1 (en) | 2004-09-09 | 2006-06-22 | Kick George F | Expandable trans-septal sheath |
ES2529451T3 (en) | 2004-09-23 | 2015-02-20 | Vasgene Therapeutics, Inc. | Polypeptide compounds to inhibit angiogenesis and tumor growth |
JP2008514345A (en) | 2004-10-02 | 2008-05-08 | クリストフ・ハンス・フーバー | Device for treating or replacing a heart valve or surrounding tissue without requiring full cardiopulmonary support |
US7682335B2 (en) | 2004-10-15 | 2010-03-23 | Futurematrix Interventional, Inc. | Non-compliant medical balloon having an integral non-woven fabric layer |
US20100294147A1 (en) | 2004-12-20 | 2010-11-25 | Nanoink, Inc. | Apparatus and methods for preparing identification features including pharmaceutical applications |
AU2006204045B2 (en) | 2005-01-05 | 2010-10-14 | Board Of Regents, The University Of Texas System | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
BRPI0609143A2 (en) | 2005-03-17 | 2011-09-13 | Ind Origami Llc | sheet material for forming a three-dimensional structural structure, hollow beam and exoskeleton frame |
US20060247672A1 (en) | 2005-04-27 | 2006-11-02 | Vidlund Robert M | Devices and methods for pericardial access |
EP1883371B1 (en) | 2005-05-25 | 2015-10-07 | Covidien LP | System and method for delivering and deploying and occluding device within a vessel |
US7767710B2 (en) | 2005-05-25 | 2010-08-03 | Calosyn Pharma, Inc. | Method for treating osteoarthritis |
US8252905B2 (en) | 2005-06-03 | 2012-08-28 | Mochida Pharmaceutical Co., Ltd. | Anti-CD14 antibody fusion protein |
US8202835B2 (en) | 2005-06-17 | 2012-06-19 | Yitzchak Hillman | Disease treatment via antimicrobial peptides or their inhibitors |
ES2437865T3 (en) | 2005-07-25 | 2014-01-14 | Foundation For Biomedical Research And Innovation | Composition in sheet form |
FR2889525A1 (en) | 2005-08-04 | 2007-02-09 | Palumed Sa | NOVEL POLYQUINOLINE DERIVATIVES AND THEIR THERAPEUTIC USE. |
US20070055206A1 (en) * | 2005-08-10 | 2007-03-08 | Guided Delivery Systems, Inc. | Methods and devices for deployment of tissue anchors |
NZ566001A (en) | 2005-08-17 | 2011-03-31 | Rochal Ind Llp | Conformable solvent-based bandage and coating material |
CN103637840A (en) | 2005-08-23 | 2014-03-19 | 史密夫和内修有限公司 | Telemetric orthopaedic implant |
GT200600381A (en) | 2005-08-25 | 2007-03-28 | ORGANIC COMPOUNDS | |
US8980246B2 (en) | 2005-09-07 | 2015-03-17 | Sillajen Biotherapeutics, Inc. | Oncolytic vaccinia virus cancer therapy |
US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US8133168B2 (en) | 2005-09-16 | 2012-03-13 | Colorado State University Research Foundation | Remediation of functional cardiac mitral valve regurgitation |
US20070072599A1 (en) | 2005-09-27 | 2007-03-29 | Romine Christopher M | Device manufacturing using the device's embedded wireless technology |
US8721597B2 (en) | 2006-11-09 | 2014-05-13 | Ncontact Surgical, Inc. | Diaphragm entry for posterior surgical access |
EP2907519A1 (en) | 2005-10-17 | 2015-08-19 | University of the Witwatersrand, Johannesburg | Osteogenic Device for Inducing Bone Formation in Clinical Contexts |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
EP1959866B1 (en) * | 2005-12-15 | 2019-03-06 | Georgia Tech Research Corporation | Papillary muscle position control devices and systems |
US20070162066A1 (en) | 2006-01-10 | 2007-07-12 | Lyon Thomas R | Clear view cannula |
US8147453B2 (en) | 2006-03-13 | 2012-04-03 | Applied Medical Resources Corporation | Balloon trocar |
US9009291B2 (en) | 2006-05-12 | 2015-04-14 | W.W. Grainger, Inc. | System and method for directing attention to web site functionality |
GB0611587D0 (en) | 2006-06-12 | 2006-07-19 | Glaxo Group Ltd | Novel compounds |
US20120277766A1 (en) | 2010-11-16 | 2012-11-01 | Anova Corporation | Apparatus and methods for closure of fissures in the anulus fibrosis |
NZ573919A (en) | 2006-06-30 | 2012-08-31 | Cvdevices Llc | A system for engaging heart tisue utilising a vacuum for percutaneous intravascular access to cardiac tissue |
US20080033241A1 (en) | 2006-08-01 | 2008-02-07 | Ruey-Feng Peh | Left atrial appendage closure |
US7877564B2 (en) | 2006-08-05 | 2011-01-25 | Benhov Gmbh, Llc | Memory configuration and method for calibrating read/write data based on performance characteristics of the memory configuration |
EP2069479A1 (en) | 2006-09-18 | 2009-06-17 | Medizinische Universität Graz | Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics |
US8220334B2 (en) | 2006-11-10 | 2012-07-17 | Penrith Corporation | Transducer array imaging system |
US9114229B2 (en) | 2006-12-29 | 2015-08-25 | St. Jude Medical, Af Division, Inc. | Dual braid reinforcement deflectable device |
US8239215B2 (en) | 2007-01-17 | 2012-08-07 | Mitochon Systems, Inc. | Apparatus and method for revenue distribution generated from delivering healthcare advertisements via EMR systems, RHIN, and electronic advertising servers |
US7722568B2 (en) | 2007-01-29 | 2010-05-25 | Onset Medical Corporation | Expandable intra-aortic balloon pump sheath |
EP2129332B1 (en) | 2007-02-16 | 2019-01-23 | Medtronic, Inc. | Replacement prosthetic heart valves |
US8156675B2 (en) | 2007-03-08 | 2012-04-17 | Browning | Firearm magazine |
US7820207B2 (en) | 2007-03-15 | 2010-10-26 | Omnica Gmbh | Stabilized anthocyanin compositions |
US8851709B2 (en) | 2007-03-30 | 2014-10-07 | Designs For Vision, Inc. | Remote control of illuminating headlamp |
US9050064B2 (en) | 2007-04-27 | 2015-06-09 | Cvdevices, Llc | Systems for engaging a bodily tissue and methods of using the same |
US20080275295A1 (en) | 2007-05-01 | 2008-11-06 | Michael Gertner | Methods of using pericardial inserts |
US8597353B2 (en) | 2007-06-06 | 2013-12-03 | Spinesmith Partners, L.P. | Interbody fusion device and associated methods |
US9186375B2 (en) | 2007-06-21 | 2015-11-17 | Arthrodynamic Technologies, Animal Health Division, Inc. | Glycosaminoglycan compositions in combination with stem cells |
US8240367B2 (en) | 2007-06-28 | 2012-08-14 | Exxonmobil Research And Engineering Company | Plate heat exchanger port insert and method for alleviating vibrations in a heat exchanger |
US8992569B2 (en) | 2007-06-29 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Insertion device and method of use |
US8230412B2 (en) | 2007-08-31 | 2012-07-24 | Apple Inc. | Compatible trust in a computing device |
CN101842111A (en) | 2007-08-31 | 2010-09-22 | 密执安州立大学董事会 | Selective cytopheresis devices and related methods thereof |
US8092363B2 (en) | 2007-09-05 | 2012-01-10 | Mardil, Inc. | Heart band with fillable chambers to modify heart valve function |
US20090068250A1 (en) | 2007-09-07 | 2009-03-12 | Philippe Gravagna | Bioresorbable and biocompatible compounds for surgical use |
AR068767A1 (en) | 2007-10-12 | 2009-12-02 | Novartis Ag | ANTIBODIES AGAINST SCLEROSTIN, COMPOSITIONS AND METHODS OF USE OF THESE ANTIBODIES TO TREAT A PATHOLOGICAL DISORDER MEDIATIONED BY SCLEROSTIN |
MX2010004124A (en) | 2007-10-15 | 2010-09-28 | Hurricanefabric Com Llc | Weather protection system. |
US20120276189A1 (en) | 2007-10-23 | 2012-11-01 | Benjamin Johnson | Therapeutic Treatment of Dermatologic Skin Disorders |
US20090114228A1 (en) | 2007-11-01 | 2009-05-07 | Garry William Kirschner | Disposable outdoors mask and method of use |
US20090170770A1 (en) | 2007-11-06 | 2009-07-02 | Ali Hafezi-Moghadam | Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor |
WO2009060437A2 (en) | 2007-11-08 | 2009-05-14 | Svip 3 Llc | Fecal incontinence device, system and method |
US9273100B2 (en) | 2007-11-09 | 2016-03-01 | Board Of Trustees Of Michigan State University | Use of Galerina marginata genes and proteins for peptide production |
US8167809B2 (en) | 2007-12-20 | 2012-05-01 | Silicon Valley Medical Instruments, Inc. | Imaging probe housing with fluid flushing |
US20120276286A1 (en) | 2008-01-17 | 2012-11-01 | Vijayakumar R | Method and Sealant for Sealing Air Filter Leaks |
US8126408B2 (en) | 2008-01-22 | 2012-02-28 | Provigent Ltd | Multi-mode wireless communication link |
US8220091B2 (en) | 2008-01-25 | 2012-07-17 | Squire Sleep Systems LLC | Sleep system |
CN105400735A (en) | 2008-01-30 | 2016-03-16 | 阿斯特利亚斯生物治疗股份公司 | Synthetic Surfaces For Culturing Stem Cell Derived Cardiomyocytes |
ITTO20080120A1 (en) | 2008-02-18 | 2009-08-19 | Tek Global Srl | SEALANT COMPOSITION FOR REPAIRING TIRES |
EP2242527A4 (en) | 2008-02-19 | 2011-07-13 | Portaero Inc | Devices and methods for delivery of a therapeutic agent through a pneumostoma |
WO2009105699A1 (en) | 2008-02-22 | 2009-08-27 | Endologix, Inc. | Design and method of placement of a graft or graft system |
US8968393B2 (en) | 2008-02-28 | 2015-03-03 | Medtronic, Inc. | System and method for percutaneous mitral valve repair |
US8252834B2 (en) | 2008-03-12 | 2012-08-28 | The Regents Of The University Of Michigan | Dendrimer conjugates |
JP2011515162A (en) | 2008-03-21 | 2011-05-19 | バイオミメディカ インコーポレイテッド | Methods, devices and compositions for adhering hydrated polymer implants to bone |
US8538509B2 (en) | 2008-04-02 | 2013-09-17 | Rhythmia Medical, Inc. | Intracardiac tracking system |
FR2929502B1 (en) | 2008-04-04 | 2011-04-08 | Clariance | NUCLEIC IMPLANT. |
US8226965B2 (en) | 2008-04-25 | 2012-07-24 | Nanobio Corporation | Methods of treating fungal, yeast and mold infections |
US8757629B2 (en) | 2008-04-29 | 2014-06-24 | Thermal Structures, Inc. | Thermal seal and methods therefor |
WO2009134768A1 (en) | 2008-05-01 | 2009-11-05 | Massachusetts Institute Of Technology (Mit) | Devices and processes for analyzing nucleic acid damage and repair using electrophoresis |
US8041175B2 (en) | 2008-05-05 | 2011-10-18 | Adc Telecommunications, Inc. | Front-access locking arrangement for sliding drawer |
CN102017065B (en) | 2008-05-09 | 2012-07-18 | Fsi国际公司 | Tools and methods for processing microelectronic workpices using process chamber designs that easily transition between open and closed modes of operation |
WO2009143409A2 (en) | 2008-05-23 | 2009-11-26 | Martin Scientific, Llc | Reliable downhole data transmission system |
US8986728B2 (en) | 2008-05-30 | 2015-03-24 | Abbott Cardiovascular Systems Inc. | Soluble implantable device comprising polyelectrolyte with hydrophobic counterions |
US9049879B2 (en) | 2008-06-13 | 2015-06-09 | International Ip Holdings Llc | Edible energy composition |
US8210090B2 (en) | 2008-07-01 | 2012-07-03 | Adcor Industries, Inc. | Firearm having an expulsion device |
US9662045B2 (en) | 2008-07-11 | 2017-05-30 | Medtronic, Inc. | Generation of sleep quality information based on posture state data |
US8291594B2 (en) | 2008-08-01 | 2012-10-23 | The Boeing Company | Attachment system and method for thermal protection system |
US8237206B2 (en) | 2008-08-12 | 2012-08-07 | United Microelectronics Corp. | CMOS image sensor, method of making the same, and method of suppressing dark leakage and crosstalk for CMOS image sensor |
US20100041506A1 (en) | 2008-08-15 | 2010-02-18 | Kenneth Cooper | Axle shaft disconnect assembly |
US20120273470A1 (en) | 2011-02-24 | 2012-11-01 | Zediker Mark S | Method of protecting high power laser drilling, workover and completion systems from carbon gettering deposits |
US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
WO2010062435A1 (en) | 2008-09-04 | 2010-06-03 | Telcordia Technologies, Inc. | Computing diagnostic explanations of network faults from monitoring data |
US8271153B2 (en) | 2008-09-11 | 2012-09-18 | General Electric Company | System, method and computer readable memory medium for verifying track database information |
AU2009291536B2 (en) | 2008-09-12 | 2012-08-16 | Xbiotech Inc. | Targeting pathogenic monocytes |
EA201100755A1 (en) | 2008-11-11 | 2011-12-30 | Бёрингер Ингельхайм Интернациональ Гмбх | METHOD OF TREATMENT OR PREVENTION OF THROMBOSIS BY USING DABIGATRANE ETHSYLATE OR ITS SALT WITH IMPROVED EFFICIENCY IN COMPARISON WITH STANDARD TREATMENT WARFARIN |
US8226601B2 (en) | 2008-11-12 | 2012-07-24 | Sanovas, Inc. | Resector balloon system |
ES2583639T3 (en) | 2008-11-28 | 2016-09-21 | Terravia Holdings, Inc. | Production of specific oils in heterotrophic microorganisms |
US8808368B2 (en) * | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
JP5659166B2 (en) | 2009-02-05 | 2015-01-28 | 武田薬品工業株式会社 | Pyridazinone compounds |
US20120277161A1 (en) | 2009-02-23 | 2012-11-01 | Inter-K Pty Limited | Inhibition of multiple cell activation pathways |
US8772339B2 (en) | 2009-02-24 | 2014-07-08 | Steven N. Mink | Ethylgallate and related compounds as a treatment for sepsis and septic shock |
US8217303B2 (en) | 2009-03-16 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Dual gas laser cutting of medical devices |
US8242248B2 (en) | 2009-03-23 | 2012-08-14 | Nodality, Inc. | Kits for multiparametric phospho analysis |
US8239629B2 (en) | 2009-03-31 | 2012-08-07 | Micron Technology, Inc. | Hierarchical memory architecture to connect mass storage devices |
US8033750B2 (en) | 2009-03-31 | 2011-10-11 | Midwest Industrial Supply, Inc. | Method and composition for modifying soil and dust control |
US8395191B2 (en) | 2009-10-12 | 2013-03-12 | Monolithic 3D Inc. | Semiconductor device and structure |
US8810796B2 (en) | 2009-04-21 | 2014-08-19 | Michigan Aerospace Corporation | Light processing system and method |
US9050129B2 (en) | 2009-04-24 | 2015-06-09 | Medtronic, Inc. | Auto-closure apical access positioner device and method |
EP2422045A2 (en) | 2009-04-24 | 2012-02-29 | Completion Technology Ltd. | Processes and systems for treating oil and gas wells |
WO2010138580A2 (en) | 2009-05-26 | 2010-12-02 | Tissue Solutions, Llc | Filamentous tissue implant |
US9040238B2 (en) | 2009-06-22 | 2015-05-26 | Max-Delbrück-Centrum Für Molekulare Medizin Berlin-Buch | Polynucleotides for use in medicine |
US8920369B2 (en) | 2009-06-24 | 2014-12-30 | Shifamed Holdings, Llc | Steerable delivery sheaths |
US9474900B2 (en) | 2009-06-30 | 2016-10-25 | Bjarne Geiges | Polarization device and implantation device |
WO2011006249A1 (en) | 2009-07-13 | 2011-01-20 | Université de Montréal | Mutated sumo isoforms and uses thereof |
US8287896B2 (en) | 2010-01-06 | 2012-10-16 | The Curators Of The University Of Missouri | Scaffolds with trace element for tissue regeneration in mammals |
WO2011011513A1 (en) | 2009-07-21 | 2011-01-27 | University Of Washington Through Its Center For Commercialization | Inhibition of pathological bone formation |
US20120277110A1 (en) | 2009-07-24 | 2012-11-01 | Fabrice Andre | Parp and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer |
CA2769456A1 (en) | 2009-07-31 | 2011-02-03 | Chromocell Corporation | Methods and compositions for identifying and validating modulators of cell fate |
US8465471B2 (en) | 2009-08-05 | 2013-06-18 | Rocin Laboratories, Inc. | Endoscopically-guided electro-cauterizing power-assisted fat aspiration system for aspirating visceral fat tissue within the abdomen of a patient |
AU2010280768B2 (en) | 2009-08-06 | 2015-01-22 | Dsm Ip Assets B.V. | Surgical repair article based on HPPE material |
BR112012002336A2 (en) | 2009-08-07 | 2016-05-31 | Merck Patent Gmbh | azaheterocyclic compounds |
US8210085B2 (en) | 2009-08-27 | 2012-07-03 | Ethicon, Inc. | Automated systems and methods for making braided barbed sutures |
MX2012002755A (en) | 2009-09-04 | 2013-12-02 | William J Kitchen | Stationary track with gimbaled rider carriages amusement ride. |
GB2473265A (en) | 2009-09-07 | 2011-03-09 | Sonovia Ltd | Flexible PCB mounting for ultrasonic transducers |
EP2475379B1 (en) | 2009-09-07 | 2017-05-10 | The Regents of the University of Colorado, A Body Corporate | Cd117+cells for use in islet cell transplantation |
WO2011037565A1 (en) | 2009-09-23 | 2011-03-31 | Hewlett-Packard Development Company, L.P. | Providing in rush current tolerance to an electronic device |
EP2790132A3 (en) | 2009-09-24 | 2014-10-29 | Terrara Code Research Institute, Inc. | RFID tag |
US20120273439A1 (en) | 2009-09-25 | 2012-11-01 | Production Plus Corporation | Electrically conductive attachment system and rack |
GB0917054D0 (en) | 2009-09-29 | 2009-11-11 | Cytoguide As | Agents, uses and methods |
US8261444B2 (en) | 2009-10-07 | 2012-09-11 | General Electric Company | Turbine rotor fabrication using cold spraying |
US20120278865A1 (en) | 2009-10-09 | 2012-11-01 | Kip Sawdy | Method, system and apparatus for identification |
WO2011041874A1 (en) | 2009-10-09 | 2011-04-14 | Uview Ultraviolet Systems Inc. | Air conditioning lubricant delivery vessel, method and system |
US8979820B2 (en) | 2009-10-09 | 2015-03-17 | Cynthia S. Bailey | Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes |
US8295912B2 (en) | 2009-10-12 | 2012-10-23 | Kona Medical, Inc. | Method and system to inhibit a function of a nerve traveling with an artery |
EP2488187A4 (en) | 2009-10-13 | 2014-03-26 | Allocure Inc | Assay for the prediction of therapeutic effectiveness of mesenchymal stromal cells, and methods of using same |
WO2011046616A2 (en) | 2009-10-15 | 2011-04-21 | New York University | Methods for modulating bacterial infection |
US8281951B2 (en) | 2009-10-15 | 2012-10-09 | Leviton Manufacturing Co., Inc. | Electrical component enclosure |
WO2011046570A1 (en) | 2009-10-16 | 2011-04-21 | The University Of Medicine And Dentistry Of New Jersey | Method for treating chronic nerve tissue injury using a cell therapy strategy |
EP2491140A1 (en) | 2009-10-19 | 2012-08-29 | Stichting Het Nederlands Kanker Instituut | Predicting response to anti-cancer therapy via array comparative genomic hybridization |
GB0918392D0 (en) | 2009-10-20 | 2009-12-02 | Novartis Ag | Diagnostic and therapeutic methods |
ES2556639T3 (en) | 2009-10-21 | 2016-01-19 | The Scripps Research Institute | Method for using non-rare cells to detect rare cells |
DK2491056T3 (en) | 2009-10-22 | 2021-10-25 | Univ Twente | VHH FOR USE IN TISSUE REPAIR, ORGAN REGENERATION, ORGAN REPLACEMENT AND TISSUE CONSTRUCTION |
GB0918940D0 (en) | 2009-10-28 | 2009-12-16 | Norsk Inst For Skog Og Landska | Method |
WO2011051390A1 (en) | 2009-10-28 | 2011-05-05 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Homologous recombination in the oocyte |
US8690939B2 (en) * | 2009-10-29 | 2014-04-08 | Valtech Cardio, Ltd. | Method for guide-wire based advancement of a rotation assembly |
FR2952233B1 (en) | 2009-10-30 | 2011-12-16 | Michelin Soc Tech | PROCEDURE FOR DETECTING THE STATE OF A FUEL CELL. |
BR112012009172A2 (en) | 2009-10-30 | 2016-11-22 | Dieffenbacher Gmbh Maschinen | granulating press to produce granules |
EP2327733A1 (en) | 2009-10-30 | 2011-06-01 | Sika Technology AG | Non-Crystallising Bis-Oxazolidines |
RU2568549C2 (en) | 2009-10-30 | 2015-11-20 | Диффенбахер Гмбх Машинен- Унд Анлагенбау | Pelletizing press for production of pellets |
US20120277144A1 (en) | 2009-11-04 | 2012-11-01 | Henricus Johannes Duckers | Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
DE102009051939A1 (en) | 2009-11-04 | 2011-05-05 | Dieffenbacher Gmbh + Co. Kg | Press with a directly driven crank mechanism, press line of such presses and a method for producing a press with at least one direct drive. |
US8703751B2 (en) | 2009-11-09 | 2014-04-22 | The Regents Of The University Of California | Androstenediol as an indicator for assessing estrogenicity |
AU2010314827A1 (en) | 2009-11-09 | 2012-05-31 | Entourage Medical Technologies, Inc. | System for providing access and closure to tissue |
US8226657B2 (en) | 2009-11-10 | 2012-07-24 | Carefusion 207, Inc. | Systems and methods for vertebral or other bone structure height restoration and stabilization |
EP2498824B1 (en) | 2009-11-11 | 2016-04-20 | University of Twente, Institute for Biomedical Technology and Technical Medicine (MIRA) | Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers |
US8264631B2 (en) | 2009-11-11 | 2012-09-11 | Au Optronics Corporation | Common repair structures for close bus in a liquid crystal display |
CN107574131A (en) | 2009-11-11 | 2018-01-12 | 营养健康有限公司 | Probiotic bifidobacterium strains |
DE102009046670A1 (en) | 2009-11-12 | 2011-05-19 | Dieffenbacher Gmbh + Co. Kg | Plant for the production of fiber-reinforced molded parts and method for operating a plant for the production of fiber-reinforced molded parts |
EP2322134B1 (en) | 2009-11-12 | 2012-09-12 | BonAlive Biomaterials Oy | Implantable paste and its use |
WO2011057774A2 (en) | 2009-11-12 | 2011-05-19 | Services Petroliers Schlumberger | Integrated choke manifold system for use in a well application |
US8268389B2 (en) | 2010-01-08 | 2012-09-18 | International Business Machines Corporation | Precast thermal interface adhesive for easy and repeated, separation and remating |
WO2011060249A2 (en) | 2009-11-13 | 2011-05-19 | The Brigham And Women's Hospital, Inc. | Methods and apparatus for vascular anastomosis |
US20120276139A1 (en) | 2009-11-16 | 2012-11-01 | Stichting Dienst Landbouwkundig Onderzoek | Use of newcastle disease virus-based vector for inducing an immune response in mammals |
US20120276365A1 (en) | 2009-11-23 | 2012-11-01 | William Petuskey | Refractory Porous Ceramics |
EP2504472A1 (en) | 2009-11-24 | 2012-10-03 | Collplant Ltd. | Method of generating collagen fibers |
CA2779374A1 (en) | 2009-11-25 | 2011-06-03 | Diversey, Inc. | Surface coating system and method of using surface coating system |
CN102639325A (en) | 2009-11-25 | 2012-08-15 | 泰华施公司 | Surface coating system and method |
CA2781341C (en) | 2009-11-25 | 2015-05-12 | Wlodzimierz Myslowski | Method for production of granulated polymer -asphalt binder and sulfur concrete with participation of sulfur polymer obtained in waste sulfur solvent - borne modification |
EP2327412A1 (en) | 2009-11-30 | 2011-06-01 | Universitätsklinikum Hamburg-Eppendorf | Treatment of nerve injuries |
WO2011067770A1 (en) * | 2009-12-02 | 2011-06-09 | Valtech Cardio, Ltd. | Delivery tool for implantation of spool assembly coupled to a helical anchor |
US20120278123A1 (en) | 2009-12-02 | 2012-11-01 | Houle Dale T | Method And System For Determining The Capacity Required To Complete Work During Planned Start And Finished Times |
JP6025255B2 (en) | 2009-12-10 | 2016-11-16 | ターンストーン リミテッド パートナーシップ | Oncolytic rhabdovirus |
US8747775B2 (en) | 2009-12-11 | 2014-06-10 | Food Technologies International, LLC | Food safety indicator |
FR2953747B1 (en) | 2009-12-14 | 2012-03-23 | Snecma | PROCESS FOR REPAIRING TITANIUM VANE BY LASER RECHARGING AND MODERATE HIP COMPRESSION |
WO2011084342A1 (en) | 2009-12-17 | 2011-07-14 | Cook Medical Technologies Llc | Delivery system with retractable proximal end |
FI20096351A0 (en) | 2009-12-18 | 2009-12-18 | Pekka Vallittu | implant |
BR112012015034A2 (en) | 2009-12-18 | 2016-08-23 | Du Pont | water-based coating composition, use and process for multi-layer coating of substrates |
BR112012014146B8 (en) | 2009-12-18 | 2022-08-30 | Camfil Ventures Ab | INSTALLATION WITH AIR INLET |
BR112012015410A2 (en) | 2009-12-21 | 2016-11-29 | Suntory Holdings Ltd | diacylglycerol acyltransferase genes and their use. |
JP5816192B2 (en) | 2009-12-21 | 2015-11-18 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Processing method and image forming system |
DE102009060437A1 (en) | 2009-12-22 | 2011-06-30 | Konstantin Dr.-Ing. 66386 Kelaiditis | Device for the use of flow energy |
CN102665482B (en) | 2009-12-23 | 2015-06-17 | 高露洁-棕榄公司 | Oral care system |
WO2011078863A1 (en) | 2009-12-23 | 2011-06-30 | Colgate-Palmolive Company | Oral care system |
KR101414966B1 (en) | 2009-12-23 | 2014-07-04 | 콜게이트-파아므올리브캄파니 | Oral care system, kit and method |
KR101267813B1 (en) | 2009-12-30 | 2013-06-04 | 주식회사 삼양바이오팜 | An injectable composition comprising polymeric nanoparticles containing rapamycin with an improved water solubility and a method for preparing the same, and an anticancer composition comprising the same for a combination therapy with radiation |
EP2519792B1 (en) | 2009-12-31 | 2017-08-16 | LG Electronics Inc. | Refrigerator and control method thereof |
US9138441B2 (en) | 2009-12-31 | 2015-09-22 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
ES2673726T3 (en) | 2010-01-05 | 2018-06-25 | Cell Constructs I, Llc | Biomaterials made from human hair |
US20120276552A1 (en) | 2010-01-05 | 2012-11-01 | University Of Cincinnati | Serum spla2-iia as diagnosis marker for prostate and lung cancer |
US20120276581A1 (en) | 2010-01-07 | 2012-11-01 | Core Dynamics Ltd. | Method for preserving cancellous bone samples and preserved cancellous bone tissue |
EP2523724B1 (en) | 2010-01-12 | 2015-08-19 | The Johns Hopkins University | Implantable vestibular prosthesis |
WO2011091019A1 (en) | 2010-01-19 | 2011-07-28 | University Of Tennessee Research Foundation | Methods and compositions for treating and preventing parenteral nutrition associated liver disease |
JP5578864B2 (en) | 2010-01-20 | 2014-08-27 | 三菱重工業株式会社 | Repair method of wall member with flow path |
US8238178B2 (en) | 2010-02-12 | 2012-08-07 | Taiwan Semiconductor Manufacturing Company, Ltd. | Redundancy circuits and operating methods thereof |
SE535140C2 (en) * | 2010-03-25 | 2012-04-24 | Jan Otto Solem | An implantable device, kit and system for improving cardiac function, including means for generating longitudinal movement of the mitral valve |
US8363475B2 (en) | 2010-03-30 | 2013-01-29 | Ememory Technology Inc. | Non-volatile memory unit cell with improved sensing margin and reliability |
US11337707B2 (en) | 2010-05-25 | 2022-05-24 | Miracor Medical Sa | Treating heart tissue |
KR101484126B1 (en) | 2010-05-26 | 2015-01-28 | 도요타 지도샤(주) | Fuel cell stack, manufacturing method of fuel cell stack and replacement method of module as constituent of fuel cell stack |
US8623285B2 (en) | 2010-05-27 | 2014-01-07 | Shawn Grannell | Ammonia flame cracker system, method and apparatus |
US9125657B2 (en) | 2010-06-22 | 2015-09-08 | Covidien Lp | Methods and apparatus for storage and/or introduction of implant for hollow anatomical structure |
EP2407487A1 (en) | 2010-07-14 | 2012-01-18 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Multispecific modular antibody |
US8571634B2 (en) | 2010-07-23 | 2013-10-29 | David R. Hubbard | Method to diagnose and measure vascular drainage insufficiency in the central nervous system |
CN101924469B (en) | 2010-08-06 | 2012-10-24 | 东南大学 | Switching power supply with fast transient response |
WO2012040865A1 (en) | 2010-10-01 | 2012-04-05 | Alberto Weber | Medical apparatus and method for heart valve repair |
MX338421B (en) | 2010-10-07 | 2016-04-15 | Ac Immune Sa | Phosphospecific antibodies recognising tau. |
US20120278200A1 (en) | 2010-10-21 | 2012-11-01 | Van Coppenolle Bart P E | Value Banking System And Technique Utilizing Complementary Value Currency |
GB2484952B (en) | 2010-10-27 | 2012-09-26 | Cook Medical Technologies Llc | Valvuloplasty balloon catheter |
US20120272815A1 (en) | 2010-10-29 | 2012-11-01 | Anaren, Inc. | Magnetic Instrument Pickup |
US20120277999A1 (en) | 2010-10-29 | 2012-11-01 | Pbd Biodiagnostics, Llc | Methods, kits and arrays for screening for, predicting and identifying donors for hematopoietic cell transplantation, and predicting risk of hematopoietic cell transplant (hct) to induce graft vs. host disease (gvhd) |
US20120276509A1 (en) | 2010-10-29 | 2012-11-01 | The Cleveland Clinic Foundation | System of preoperative planning and provision of patient-specific surgical aids |
KR20180059560A (en) | 2010-10-29 | 2018-06-04 | 애브비 인코포레이티드 | Solid dispersions containing an apoptosis-inducing agent |
US8394006B2 (en) | 2010-11-19 | 2013-03-12 | Kensey Nash Corporation | Centrifuge |
US8608738B2 (en) | 2010-12-06 | 2013-12-17 | Soulor Surgical, Inc. | Apparatus for treating a portion of a reproductive system and related methods of use |
KR101293635B1 (en) | 2010-12-29 | 2013-08-05 | 주식회사 엘지화학 | Apparatus and method for managing battery pack based on retrogression degree of secondary electric cell and battery pack using it |
WO2012097086A1 (en) | 2011-01-11 | 2012-07-19 | Amsel Medical Corporation | Method and apparatus for treating varicose veins |
US20120191128A1 (en) | 2011-01-25 | 2012-07-26 | Wound Care 360?, Inc. | Vascular wound closing apparatus and method |
JP2014511365A (en) | 2011-01-27 | 2014-05-15 | バクスター・インターナショナル・インコーポレイテッド | Use of (S) -esmolol to modulate venous stimulation associated with the treatment of cardiac disorders |
JP2014511218A (en) * | 2011-02-01 | 2014-05-15 | セント・ジュード・メディカル,インコーポレイテッド | Apparatus and method for heart valve repair |
EP2670849A1 (en) | 2011-02-03 | 2013-12-11 | Mirna Therapeutics, Inc. | Synthetic mimics of mir-124 |
US8906397B2 (en) | 2011-02-07 | 2014-12-09 | Professional Compounding Centers of America, Ltd | Permeation enhancers for topical formulations |
US8944338B2 (en) | 2011-02-24 | 2015-02-03 | Google Inc. | Thermostat with self-configuring connections to facilitate do-it-yourself installation |
US20120276084A1 (en) | 2011-02-25 | 2012-11-01 | The Brigham And Women's Hospital, Inc. | Predicting Risk of Age-Related Macular Degeneration |
EP2678453A4 (en) | 2011-02-25 | 2015-07-15 | Lab Corp America Holdings | Methods and compositions for determining virus susceptibility to integrase inhibitors |
US20120277155A1 (en) | 2011-02-25 | 2012-11-01 | Medtronic, Inc. | Therapy for kidney disease and/or heart failure |
ES2748430T3 (en) | 2011-02-28 | 2020-03-16 | Seattle Childrens Res Institute | Coupling endonucleases with end-processing enzymes that drive high-efficiency gene disruption |
US8694866B2 (en) | 2011-03-15 | 2014-04-08 | California Institute Of Technology | MDS array codes with optimal building |
JP5594198B2 (en) | 2011-03-16 | 2014-09-24 | 富士通株式会社 | Electronic component and electronic component assembling apparatus |
US20120278236A1 (en) | 2011-03-21 | 2012-11-01 | Qualcomm Incorporated | System and method for presentment of nonconfidential transaction token identifier |
US9046342B2 (en) | 2011-04-01 | 2015-06-02 | Habsonic, Llc | Coaxial cable Bragg grating sensor |
US20120278242A1 (en) | 2011-04-01 | 2012-11-01 | Massachusetts Institute Of Technology | System and method for providing product data collection, monitoring, and tracking |
EP2694060A4 (en) | 2011-04-01 | 2014-09-10 | Univ Utah Res Found | Substituted 3-(1h-benzo{d}imidazol-2-yl)-1h-indazole-analogs as inhibitors of the pdk1 kinase |
WO2012141971A2 (en) | 2011-04-05 | 2012-10-18 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for rejuvenation and expansion of stem cells |
DE102011006905A1 (en) | 2011-04-06 | 2012-10-11 | Kugler-Womako Gmbh | Machine for making books, in particular photo books and / or picture books |
CA2832300C (en) | 2011-04-06 | 2021-03-30 | Mary Kay Inc. | Topical skin care formulation comprising an extract of jasminum stephanense |
WO2013089819A2 (en) | 2011-04-08 | 2013-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Microrna mediated neuronal cell induction |
US20120277517A1 (en) | 2011-04-08 | 2012-11-01 | The Johns Hopkins University | Formulation and Methods for Enhanced Interventional Image-Guided Therapy of Cancer |
CN102252226B (en) | 2011-04-14 | 2013-01-09 | 深圳市华星光电技术有限公司 | Light-emitting diode (LED) component and LED light string adopting same |
US9028444B2 (en) | 2011-04-15 | 2015-05-12 | W. L. Gore & Associates, Inc. | Pivoting ring seal |
PL2517986T3 (en) | 2011-04-26 | 2014-03-31 | Interroll Holding Ag | Braking roller |
US20120277576A1 (en) | 2011-04-26 | 2012-11-01 | Chun Kee Lui | Echogenic infusion port catheter |
US10187494B2 (en) | 2011-04-26 | 2019-01-22 | Acumera, Inc. | Gateway device application development system |
US20120276518A1 (en) | 2011-04-26 | 2012-11-01 | John Archie Gillis | Method and Device for Perfusing Tissue by ExVivo Attachment to a Living Organism |
US9364701B2 (en) | 2011-04-26 | 2016-06-14 | Upper Core Technologies, Llc | Device and methods for accessory chest muscle development |
KR101330615B1 (en) | 2011-04-26 | 2013-11-18 | 로베르트 보쉬 게엠베하 | Rechargeable battery |
US20120276008A1 (en) | 2011-04-26 | 2012-11-01 | Spine Wave, Inc. | Radiopaque injectable nucleus hydrogel compositions |
US20120277864A1 (en) | 2011-04-26 | 2012-11-01 | Warsaw Orthopedic, Inc. | Cannula assembly with non-circular profile and method of use |
US9519496B2 (en) | 2011-04-26 | 2016-12-13 | Microsoft Technology Licensing, Llc | Detecting and preventing virtual disk storage linkage faults |
US20120278099A1 (en) | 2011-04-26 | 2012-11-01 | Cerner Innovation, Inc. | Monitoring, capturing, measuring and annotating physiological waveform data |
US8900767B2 (en) | 2011-04-26 | 2014-12-02 | GM Global Technology Operations LLC | Algorithm for in-situ quantification of PEMFC membrane health over its life |
US20120275860A1 (en) | 2011-04-26 | 2012-11-01 | Road Science, Llc | Destabilized bituminous bonding layer |
KR101282270B1 (en) | 2011-04-26 | 2013-07-10 | 주식회사 지엔원 | Apparatus for blocking the power of coilless clutch |
US20120277582A1 (en) | 2011-04-26 | 2012-11-01 | Kyphon Sarl | Devices and methods for osteolytic lesion assessment using a steerable catheter |
US8308680B1 (en) | 2011-04-26 | 2012-11-13 | Medtronic Minimed, Inc. | Selective alarms for an infusion device |
US9185824B2 (en) | 2011-04-26 | 2015-11-10 | Panduit Corp. | Cable pathway system for network architecture |
TWI617295B (en) | 2011-04-26 | 2018-03-11 | 星瑟斯有限公司 | Hinged fixation devices for combined upper jaw correction |
US9721754B2 (en) | 2011-04-26 | 2017-08-01 | Carl Zeiss Smt Gmbh | Method and apparatus for processing a substrate with a focused particle beam |
JP5351297B2 (en) | 2011-04-27 | 2013-11-27 | パナソニック株式会社 | Manufacturing method of organic EL element |
US8530980B2 (en) | 2011-04-27 | 2013-09-10 | United Microelectronics Corp. | Gate stack structure with etch stop layer and manufacturing process thereof |
US8783297B2 (en) | 2011-04-27 | 2014-07-22 | Massachusetts Institute Of Technology | Robotic system for pipeline rehabilitation |
WO2012148500A2 (en) | 2011-04-27 | 2012-11-01 | Spinesmith Partners L.P. | Interbody fusion device with lipped anterior plate and associated methods |
WO2012149492A1 (en) | 2011-04-27 | 2012-11-01 | Massachusetts Institute Of Technology | Coating compositions, methods and coated devices |
US20120273220A1 (en) | 2011-04-27 | 2012-11-01 | Bp Corporation North America Inc. | Pressure relief valve |
US9475276B2 (en) | 2011-04-27 | 2016-10-25 | Stolle Machinery Company, Llc | Can decorator machine, ink station assembly therefor, and can decorating method employing same |
WO2012148499A2 (en) | 2011-04-27 | 2012-11-01 | Spinesmith Partners Lp | Interbody fusion device with snap on anterior plate and associated methods |
US20120273389A1 (en) | 2011-04-27 | 2012-11-01 | Freescale Semiconductor, Inc. | Semiconductor tray carrier |
US8795368B2 (en) | 2011-04-27 | 2014-08-05 | Warsaw Orthopedic, Inc. | Expandable implant system and methods of use |
US9121439B2 (en) | 2011-04-27 | 2015-09-01 | Dura Global Technologies, Llc | Multi-piece shifter cable system |
US9810533B2 (en) | 2011-04-27 | 2017-11-07 | Trimble Inc. | Railway track monitoring |
CN102760697B (en) | 2011-04-27 | 2016-08-03 | 株式会社半导体能源研究所 | The manufacture method of semiconductor device |
KR102068107B1 (en) | 2011-04-27 | 2020-01-20 | 아미리스 인코퍼레이티드 | Methods for genomic modification |
US9014049B2 (en) | 2011-04-27 | 2015-04-21 | Cisco Technology, Inc. | Selectively populating forwarding information bases in a packet switch |
US8968760B2 (en) | 2011-04-27 | 2015-03-03 | Covidien Lp | Attachment of a biomaterial to tissue |
US8570788B2 (en) | 2011-04-27 | 2013-10-29 | Apple Inc. | Method and apparatus for power domain isolation during power down |
US20120272876A1 (en) | 2011-04-27 | 2012-11-01 | Bergeron Martin | Maple syrup evaporator with biomass burner |
WO2012148840A2 (en) | 2011-04-27 | 2012-11-01 | Bp Corporation North America Inc. | Weighted pressure relief valve |
US8922063B2 (en) | 2011-04-27 | 2014-12-30 | Green Charge Networks, Llc | Circuit for rendering energy storage devices parallelable |
US8721728B2 (en) | 2011-04-27 | 2014-05-13 | Biomet Manufacturing, Llc | Modular glenoid prosthesis |
US8789852B2 (en) | 2011-04-27 | 2014-07-29 | Hosebee, Llc | Hose repair clamp |
US20120278195A1 (en) | 2011-04-27 | 2012-11-01 | Douglas Joseph | Method for locating a provider and a provider locating system |
US9036173B2 (en) | 2011-04-27 | 2015-05-19 | Xerox Corporation | Methods and systems to troubleshoot malfunctions in multifunction devices using a wireless handheld device |
US8857520B2 (en) | 2011-04-27 | 2014-10-14 | Wild Well Control, Inc. | Emergency disconnect system for riserless subsea well intervention system |
US8729957B2 (en) | 2011-04-28 | 2014-05-20 | Zoll Circulation, Inc. | Battery management system with MOSFET boost system |
DE102011017695B4 (en) | 2011-04-28 | 2023-11-09 | Zf Friedrichshafen Ag | Device for actuating a transmission device with several electrohydraulically actuated frictional and positive switching elements |
US8790087B2 (en) | 2011-04-28 | 2014-07-29 | Hamilton Sundstrand Corporation | Interlocking blade sheath |
US8584729B2 (en) | 2011-04-28 | 2013-11-19 | Lauren H Fillmore | Mechanism for raising and lowering a dual shade covering a window |
WO2012149474A2 (en) | 2011-04-28 | 2012-11-01 | Zoll Circulation, Inc. | Viral distribution of battery management parameters |
GB2490348B (en) | 2011-04-28 | 2013-12-25 | Rolls Royce Plc | A head part of an annular combustion chamber |
CA2834654A1 (en) | 2011-04-28 | 2012-11-01 | Zoll Circulation, Inc. | Battery management system for control of lithium power cells |
US20120273141A1 (en) | 2011-04-28 | 2012-11-01 | Qualitas Manufacturing, Inc. | Manual Drive Mechanism for Rolling Protective Shutters |
US8689866B2 (en) | 2011-04-28 | 2014-04-08 | Canrig Drilling Technology Ltd. | Automated systems and methods for make-up and break-out of tubulars |
US9940440B2 (en) | 2011-04-28 | 2018-04-10 | Medtronic, Inc. | Detecting and responding to software and hardware anomalies in a fluid delivery system |
US9314205B2 (en) | 2011-04-28 | 2016-04-19 | Medtronic, Inc. | Measurement of cardiac cycle length and pressure metrics from pulmonary arterial pressure |
US8790650B2 (en) | 2011-04-28 | 2014-07-29 | Vanderbilt University | Methods of using an antibody to inhibit WNT-mediated cardiac remodeling |
US8427787B2 (en) | 2011-04-28 | 2013-04-23 | Entrotech, Inc. | Hard disk drives with improved exiting regions for electrical connectors and related methods |
US20120278760A1 (en) | 2011-04-28 | 2012-11-01 | Medtronic, Inc. | Predictive background data transfer for implantable medical devices |
WO2012149269A2 (en) | 2011-04-28 | 2012-11-01 | Abb Technology Ag | Determination of cd and/or md variations from scanning measurements of a sheet of material |
US9017711B2 (en) | 2011-04-28 | 2015-04-28 | Warsaw Orthopedic, Inc. | Soft tissue wrap |
US9063747B2 (en) | 2011-04-28 | 2015-06-23 | Freescale Semiconductor, Inc. | Microprocessor systems and methods for a combined register file and checkpoint repair register |
US9707257B2 (en) | 2011-04-28 | 2017-07-18 | The University Of Notre Dame | Anti-HIV group I introns and uses thereof in treating HIV infections |
US8723468B2 (en) | 2011-04-28 | 2014-05-13 | Aurora Office Equipment Co., Ltd. | Cooled motor |
KR102109309B1 (en) | 2011-04-28 | 2020-05-12 | 라이프셀 코포레이션 | Method for enzymatic treatment of tissue products |
US9649341B2 (en) | 2011-04-28 | 2017-05-16 | Warsaw Orthopedic, Inc. | Collagen matrix for tissue engineering |
US8591543B2 (en) | 2011-04-28 | 2013-11-26 | Cardiotulip Llc | Devices and methods for closure of a patent foramen ovale |
US8657001B2 (en) | 2011-04-28 | 2014-02-25 | Enventure Global Technology, L.L.C. | Downhole release joint |
JP4910071B1 (en) | 2011-04-28 | 2012-04-04 | 昭男 平根 | Sheet metal repair jig |
WO2012149292A2 (en) | 2011-04-28 | 2012-11-01 | Stemit Enterprises, Llc | Apparatus and method for facilitating bladder removal |
US20120277324A1 (en) | 2011-04-28 | 2012-11-01 | Eastman Chemical Company | Betaine esters and process for making and using |
AU2012249536B2 (en) | 2011-04-28 | 2016-09-22 | Amgen (Europe) GmbH | Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases |
KR101357759B1 (en) | 2011-04-28 | 2014-02-03 | 에스케이하이닉스 주식회사 | Semiconductor integrated circuit and semiconductor memory device having fuse circuit |
GB201107090D0 (en) | 2011-04-28 | 2011-06-08 | Rolls Royce Plc | A head part of an annular combustion chamber |
JP2014518058A (en) | 2011-04-28 | 2014-07-24 | ゾール サーキュレイション インコーポレイテッド | System and method for automatically detecting battery insertion |
US20120273142A1 (en) | 2011-04-28 | 2012-11-01 | Qualitas Manufacturing, Inc. | Manual Drive Mechanism for Rolling Protective Shutters |
JP5746553B2 (en) | 2011-04-28 | 2015-07-08 | 株式会社東芝 | Substrate processing system and substrate processing program |
US20120277798A1 (en) | 2011-04-28 | 2012-11-01 | Warsaw Orthopedic, Inc. | Spinal Rod Construct to Limit Facet Impingement |
US8593760B2 (en) | 2011-04-28 | 2013-11-26 | Entrotech, Inc. | Hard disk drives with electrical connectors comprising a flexible circuit extending through an opening in the base and related methods |
US9358460B2 (en) | 2011-04-28 | 2016-06-07 | Numecent Holdings, Inc. | Adaptive cloud-based application streaming |
US20120278913A1 (en) | 2011-04-28 | 2012-11-01 | University Of Notre Dame | Ribozyme Effector Gene in Dengue Fever Transmission and Disease Control |
US20120277544A1 (en) | 2011-04-28 | 2012-11-01 | Medtronic, Inc. | Biodegradable insertion guide for the insertion of a medical device |
US8739888B2 (en) | 2011-04-28 | 2014-06-03 | Tesco Corporation | Mechanically actuated casing drive system tool |
US9540610B2 (en) | 2011-04-28 | 2017-01-10 | Warsaw Orthopedic, Inc. | Collagen and cell implant |
US8812098B2 (en) | 2011-04-28 | 2014-08-19 | Medtronic, Inc. | Seizure probability metrics |
US8813998B2 (en) | 2011-04-28 | 2014-08-26 | The Procter & Gamble Company | Dispensers for sanitary tissue products |
US9057460B2 (en) | 2011-04-28 | 2015-06-16 | Sioux Chief Mfg. Co., Inc. | Plumbing supply line and drain line mounting and finish panel |
KR20120122287A (en) | 2011-04-28 | 2012-11-07 | 에스케이하이닉스 주식회사 | Fuse circuit for semiconductor device |
US9123107B2 (en) | 2011-04-28 | 2015-09-01 | Medtronic, Inc. | Image-based analysis of implantable medical device positioning |
DE102011018986A1 (en) | 2011-04-28 | 2012-10-31 | Heraeus Noblelight Gmbh | Lamp module, in particular for spectral analysis devices |
US20120272637A1 (en) | 2011-04-28 | 2012-11-01 | Brian Kenneth Holland | Replacing an aperture in a laminated component |
US8468477B2 (en) | 2011-04-28 | 2013-06-18 | International Business Machines Corporation | Logic modification synthesis for high performance circuits |
US9206983B2 (en) | 2011-04-28 | 2015-12-08 | Siemens Energy, Inc. | Internal combustion engine hot gas path component with powder metallurgy structure |
US20120277599A1 (en) | 2011-04-28 | 2012-11-01 | Greenhut Saul E | Measurement of cardiac cycle length and pressure metrics from pulmonary arterial pressure |
JP6195558B2 (en) | 2011-04-28 | 2017-09-13 | ゾール サーキュレイション インコーポレイテッドZOLL Circulation,Inc. | System and method for tracking and storing battery performance data |
GB201107095D0 (en) | 2011-04-28 | 2011-06-08 | Rolls Royce Plc | A head part of an annular combustion chamber |
KR20120122220A (en) | 2011-04-28 | 2012-11-07 | 에스케이하이닉스 주식회사 | Semiconductor memory device and repair method of semiconductor memory device |
US9085068B2 (en) | 2011-04-28 | 2015-07-21 | Schley Products, Inc. | Pitman arm removal tool and method |
JP5187409B2 (en) | 2011-04-28 | 2013-04-24 | トヨタ自動車株式会社 | Air-fuel ratio variation abnormality detection device |
US8740558B2 (en) | 2011-04-29 | 2014-06-03 | United Technologies Corporation | External threaded mount attachment for fan case |
NZ592576A (en) | 2011-04-29 | 2013-09-27 | Jenkin Timber Ltd | A fixing system for cladding and a cladded structure |
WO2012146383A1 (en) | 2011-04-29 | 2012-11-01 | Grünenthal GmbH | Tapentadol for preventing and treating depression and anxiety |
US8558132B2 (en) | 2011-04-29 | 2013-10-15 | National Presort, Inc. | Document sorting machine |
US8474060B2 (en) | 2011-04-29 | 2013-06-25 | Bruker Nano, Inc. | Scanning probe microscope with compact scanner |
WO2012149328A1 (en) | 2011-04-29 | 2012-11-01 | Boston Scientific Scimed, Inc. | Protective surfaces for drug-coated medical devices |
KR20120122378A (en) | 2011-04-29 | 2012-11-07 | 삼성전기주식회사 | Image recording system for front side of vehicle |
US20120273161A1 (en) | 2011-04-29 | 2012-11-01 | Ford Global Technologies, Llc | Heat Exchanger |
US8439326B2 (en) | 2011-04-29 | 2013-05-14 | Esco Tool | Safety tether for pipe end prep tool |
FR2974576B1 (en) | 2011-04-29 | 2013-07-19 | Sanofi Aventis | N - [(1H-PYRAZOL-1-YL) ARYL] -1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS |
US8530772B2 (en) | 2011-04-29 | 2013-09-10 | National Presort, Inc. | Document sorting machine |
US9456755B2 (en) | 2011-04-29 | 2016-10-04 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
US9109198B2 (en) | 2011-04-29 | 2015-08-18 | General Electric Company | Automated systems and methods for isolating regenerative cells from adipose tissue |
US9687227B2 (en) | 2011-04-29 | 2017-06-27 | Covidien Lp | Apparatus and method of forming barbs on a suture |
US9623206B2 (en) | 2011-04-29 | 2017-04-18 | Cook Medical Technologies Llc | Catheter having a selectively variable degree of flexibility |
US8728081B2 (en) | 2011-04-29 | 2014-05-20 | Warsaw Orthopedic, Inc. | Bone tamp and methods of use |
US20120272495A1 (en) | 2011-04-29 | 2012-11-01 | Leroy Hildebrandt | Fence Repair System And Method Of Use |
US9649494B2 (en) | 2011-04-29 | 2017-05-16 | Medtronic, Inc. | Electrical stimulation therapy based on head position |
US20120275927A1 (en) | 2011-04-29 | 2012-11-01 | Hotaek Rhim | Water-leak Damage Prevention System Utilizing A Unitized Tank Collection Flange Reservoir System |
WO2012149558A1 (en) | 2011-04-29 | 2012-11-01 | Chamberlin D Eric | Systems and methods for eliciting a therapeutic zone |
TWI428156B (en) | 2011-04-29 | 2014-03-01 | Far Eastern New Century Corp | Composite particles, a preparation method thereof and its application |
US20120276152A1 (en) | 2011-04-29 | 2012-11-01 | Syed Hossainy | Systems and methods of using zinc-chelator to treat myocardial infarction |
HUE049207T2 (en) | 2011-04-29 | 2020-09-28 | Penn State Res Found | Small molecule trail gene induction by normal and tumor cells as an anticancer therapy |
US9011133B2 (en) | 2011-04-29 | 2015-04-21 | Covidien Lp | Apparatus and method of forming barbs on a suture |
US8543280B2 (en) | 2011-04-29 | 2013-09-24 | Toyota Motor Engineering & Manufacturing North America, Inc. | Collaborative multi-agent vehicle fault diagnostic system and associated methodology |
KR20120122379A (en) | 2011-04-29 | 2012-11-07 | 삼성전기주식회사 | Image recording system for front side of vehicle and reflection unit |
CN103502269A (en) | 2011-04-29 | 2014-01-08 | 先锋国际良种公司 | Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance |
US9789307B2 (en) | 2011-04-29 | 2017-10-17 | Medtronic, Inc. | Dual prophylactic and abortive electrical stimulation |
KR20120122549A (en) | 2011-04-29 | 2012-11-07 | 에스케이하이닉스 주식회사 | Semiconductor memory device and repair method of the same |
US20120274440A1 (en) | 2011-04-29 | 2012-11-01 | General Electric Company | Method and system to disconnect a utility service based on seismic activity |
US9878161B2 (en) | 2011-04-29 | 2018-01-30 | Medtronic, Inc. | Entrainment of bioelectrical brain signals |
US20120272660A1 (en) | 2011-04-29 | 2012-11-01 | Proenergy Services, Llc | Method and assembly for retrofitting a gas turbine combustor end cover |
US20120272624A1 (en) | 2011-04-29 | 2012-11-01 | Kinex Cappers Llc | Semi-automated cap securing apparatus |
US8801049B2 (en) | 2011-04-29 | 2014-08-12 | Springseal, Inc. | Pipe coupling system and method |
US9243604B2 (en) | 2011-04-29 | 2016-01-26 | James Scott MONTGOMERY | In-pipe turbine |
US8335524B2 (en) | 2011-04-29 | 2012-12-18 | Navteq B.V. | Method and system for providing location targeted advertisements |
KR20120122594A (en) | 2011-04-29 | 2012-11-07 | 에스케이하이닉스 주식회사 | Semiconductor Apparatus |
US10448889B2 (en) | 2011-04-29 | 2019-10-22 | Medtronic, Inc. | Determining nerve location relative to electrodes |
US8641101B2 (en) | 2011-04-29 | 2014-02-04 | Hamilton Sundstrand Corporation | Oil transfer tube and assembly |
US9700717B2 (en) | 2011-04-29 | 2017-07-11 | Chalfont LLC | Apparatus and method for treating and preventing formation of pressure ulcers |
JP6066997B2 (en) | 2011-05-01 | 2017-01-25 | ラッカス ワイヤレス, インコーポレイテッド | Remote cable access point reset |
US20130041395A1 (en) | 2011-08-09 | 2013-02-14 | Didier De Canniere | Introductory assembly and method for inserting intracardiac instruments |
US9566443B2 (en) | 2013-11-26 | 2017-02-14 | Corquest Medical, Inc. | System for treating heart valve malfunction including mitral regurgitation |
-
2012
- 2012-11-30 US US13/691,087 patent/US20140142689A1/en not_active Abandoned
-
2013
- 2013-08-15 US US13/967,647 patent/US10159571B2/en active Active
- 2013-11-20 AU AU2013348100A patent/AU2013348100C1/en not_active Ceased
- 2013-11-20 CA CA2891356A patent/CA2891356A1/en not_active Abandoned
- 2013-11-20 EP EP13856513.0A patent/EP2922502B1/en active Active
- 2013-11-20 JP JP2015544111A patent/JP2015535465A/en active Pending
- 2013-11-20 WO PCT/US2013/070972 patent/WO2014081809A2/en active Application Filing
-
2015
- 2015-05-20 IL IL238933A patent/IL238933A0/en unknown
-
2018
- 2018-01-17 JP JP2018005752A patent/JP2018061855A/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8758393B2 (en) * | 2007-10-18 | 2014-06-24 | Neochord, Inc. | Minimally invasive repair of a valve leaflet in a beating heart |
US20110029071A1 (en) * | 2007-12-20 | 2011-02-03 | Amnon Zlotnick | Elongated body for deployment in a coronary sinus |
US20100042147A1 (en) * | 2008-08-14 | 2010-02-18 | Edwards Lifesciences Corporation | Method and apparatus for repairing or replacing chordae tendinae |
US8147542B2 (en) * | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US20100179574A1 (en) * | 2009-01-14 | 2010-07-15 | James Longoria | Synthetic chord |
US8790394B2 (en) * | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
US8408214B2 (en) * | 2010-07-08 | 2013-04-02 | Benjamin Spenser | Method for implanting prosthetic valve |
WO2013036742A1 (en) * | 2011-09-09 | 2013-03-14 | Emory University | Systems, devices and methods for repair of heart valve lesions |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150045878A1 (en) * | 2006-10-04 | 2015-02-12 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US9561105B2 (en) * | 2006-10-04 | 2017-02-07 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US20140114390A1 (en) * | 2010-01-22 | 2014-04-24 | 4Tech Inc. | Tricuspid valve repair using tension |
US10433963B2 (en) | 2010-01-22 | 2019-10-08 | 4Tech Inc. | Tissue anchor and delivery tool |
US10238491B2 (en) | 2010-01-22 | 2019-03-26 | 4Tech Inc. | Tricuspid valve repair using tension |
US10405978B2 (en) | 2010-01-22 | 2019-09-10 | 4Tech Inc. | Tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US9307980B2 (en) * | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US10813630B2 (en) | 2011-08-09 | 2020-10-27 | Corquest Medical, Inc. | Closure system for atrial wall |
US20150025312A1 (en) * | 2011-08-09 | 2015-01-22 | Didier De Canniere | Introductory assembly and method for inserting intracardiac instruments |
US10206673B2 (en) | 2012-05-31 | 2019-02-19 | 4Tech, Inc. | Suture-securing for cardiac valve repair |
US10307167B2 (en) | 2012-12-14 | 2019-06-04 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
US10314594B2 (en) | 2012-12-14 | 2019-06-11 | Corquest Medical, Inc. | Assembly and method for left atrial appendage occlusion |
US9788948B2 (en) | 2013-01-09 | 2017-10-17 | 4 Tech Inc. | Soft tissue anchors and implantation techniques |
US10449050B2 (en) | 2013-01-09 | 2019-10-22 | 4 Tech Inc. | Soft tissue depth-finding tool |
US9693865B2 (en) | 2013-01-09 | 2017-07-04 | 4 Tech Inc. | Soft tissue depth-finding tool |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US10052096B2 (en) * | 2013-11-22 | 2018-08-21 | On-X Life Technologies, Inc. | Chordal sizer |
US20150148692A1 (en) * | 2013-11-22 | 2015-05-28 | On-X Life Technologies, Inc. | Chordal Sizer |
US9801720B2 (en) | 2014-06-19 | 2017-10-31 | 4Tech Inc. | Cardiac tissue cinching |
US10085735B2 (en) * | 2014-10-29 | 2018-10-02 | Smith & Nephew, Inc. | Modular tissue repair kit and devices and method related thereto |
US20160120535A1 (en) * | 2014-10-29 | 2016-05-05 | Smith & Nephew, Inc. | Modular tissue repair kit and devices and method related thereto |
US9907547B2 (en) | 2014-12-02 | 2018-03-06 | 4Tech Inc. | Off-center tissue anchors |
US11389152B2 (en) | 2014-12-02 | 2022-07-19 | 4Tech Inc. | Off-center tissue anchors with tension members |
US10213303B2 (en) | 2015-02-02 | 2019-02-26 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae Tendinae system |
US9480565B2 (en) * | 2015-02-02 | 2016-11-01 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
WO2016126699A1 (en) * | 2015-02-02 | 2016-08-11 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
CN108697418A (en) * | 2015-11-02 | 2018-10-23 | 马里兰大学巴尔的摩分校 | Distal side anchoring device and method for mitral valve reparation |
WO2017210434A1 (en) * | 2016-06-01 | 2017-12-07 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US11103350B2 (en) | 2016-06-01 | 2021-08-31 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US11696828B2 (en) | 2016-12-30 | 2023-07-11 | Pipeline Medical Technologies, Inc. | Method and apparatus for mitral valve chord repair |
US10925731B2 (en) | 2016-12-30 | 2021-02-23 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US10617523B2 (en) | 2016-12-30 | 2020-04-14 | Pipeline Medical Technologies, Inc. | Tissue anchor with dynamic depth indicator |
US10660753B2 (en) | 2016-12-30 | 2020-05-26 | Pipeline Medical Techologies, Inc. | Leaflet capture and anchor deployment system |
US10667910B2 (en) | 2016-12-30 | 2020-06-02 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US10675150B2 (en) | 2016-12-30 | 2020-06-09 | Pipeline Medical Technologies, Inc. | Method for transvascular implantation of neo chordae tendinae |
US10548733B2 (en) | 2016-12-30 | 2020-02-04 | Pipeline Medical Technologies, Inc. | Method of transvascular prosthetic chordae tendinae implantation |
US11666441B2 (en) | 2016-12-30 | 2023-06-06 | Pipeline Medical Technologies, Inc. | Endovascular suture lock |
US10682230B2 (en) | 2016-12-30 | 2020-06-16 | Pipeline Medical Technologies, Inc. | Apparatus for transvascular implantation of neo chordae tendinae |
US11690719B2 (en) | 2016-12-30 | 2023-07-04 | Pipeline Medical Technologies, Inc. | Leaflet capture and anchor deployment system |
US9877833B1 (en) | 2016-12-30 | 2018-01-30 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US11684475B2 (en) | 2016-12-30 | 2023-06-27 | Pipeline Medical Technologies, Inc. | Method and apparatus for transvascular implantation of neo chordae tendinae |
US11083580B2 (en) | 2016-12-30 | 2021-08-10 | Pipeline Medical Technologies, Inc. | Method of securing a leaflet anchor to a mitral valve leaflet |
US10543090B2 (en) | 2016-12-30 | 2020-01-28 | Pipeline Medical Technologies, Inc. | Neo chordae tendinae deployment system |
US10799356B2 (en) | 2017-09-12 | 2020-10-13 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
USD853561S1 (en) * | 2018-02-16 | 2019-07-09 | Chengjun Guo | Implantation device |
US10925728B2 (en) * | 2018-02-22 | 2021-02-23 | Medtronic Vascular, Inc. | Prosthetic heart valve delivery systems and methods |
US20190254816A1 (en) * | 2018-02-22 | 2019-08-22 | Medtronic Vascular, Inc. | Prosthetic heart valve delivery systems and methods |
US20200222186A1 (en) * | 2019-01-16 | 2020-07-16 | Neochord, Inc. | Transcatheter methods for heart valve repair |
US20220142778A1 (en) * | 2019-01-28 | 2022-05-12 | Vesalius Cardiovascular Inc. | Apparatus for use in repairing mitral valves and method of use thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2015535465A (en) | 2015-12-14 |
EP2922502A4 (en) | 2016-08-03 |
IL238933A0 (en) | 2015-07-30 |
AU2013348100B2 (en) | 2018-05-17 |
WO2014081809A3 (en) | 2014-07-17 |
CA2891356A1 (en) | 2014-05-30 |
AU2013348100C1 (en) | 2018-06-07 |
US10159571B2 (en) | 2018-12-25 |
EP2922502B1 (en) | 2018-04-25 |
EP2922502A2 (en) | 2015-09-30 |
JP2018061855A (en) | 2018-04-19 |
WO2014081809A2 (en) | 2014-05-30 |
AU2013348100A1 (en) | 2015-05-28 |
US20140142687A1 (en) | 2014-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20140142689A1 (en) | Device and method of treating heart valve malfunction | |
JP7365392B2 (en) | mitral valve shackles | |
US20220280149A1 (en) | Suturing devices and methods for suturing an anatomic valve | |
US8292884B2 (en) | Cardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation | |
US20210220123A1 (en) | Heart valve therapeutic device | |
US8454683B2 (en) | Annuloplasty device having a helical anchor and methods for its use | |
US20070118213A1 (en) | Methods, devices, and kits for treating mitral valve prolapse | |
US20110301701A1 (en) | Method and apparatus for minimally invasive heart valve procedures | |
US20070265658A1 (en) | Anchoring and tethering system | |
US10813630B2 (en) | Closure system for atrial wall | |
US20130041395A1 (en) | Introductory assembly and method for inserting intracardiac instruments | |
JP2014523282A (en) | Minimally invasive repair of heart valve leaflets | |
US20210236287A1 (en) | Tether Attachment Assembly For Epicardial Pads And Devices And Methods Of Delivery For Same | |
US9987135B2 (en) | Devices and methods for treating functional tricuspid valve regurgitation | |
WO2020096861A1 (en) | Percutaneous anchoring for treatment of heart failure with reduced ejection fraction | |
US20230363908A1 (en) | Suture anchor for minimally invasive heart valve repair | |
CA2928434A1 (en) | Closure system for atrial wall | |
AU2014342390A1 (en) | Closure system for atrial wall |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CORQUEST MEDICAL, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DE CANNIERE, DIDIER;MOUREAUX, CHRISTOPHE;SIGNING DATES FROM 20130204 TO 20130211;REEL/FRAME:030130/0097 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |